Acrivon 治疗公司
US ˙ NasdaqGM ˙ US0048901096

介绍

本页面提供了有关 Joseph Edelman 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Joseph Edelman已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:OBIO / Orchestra BioMed Holdings, Inc. 10% Owner 5,292,556
US:ACRV / Acrivon Therapeutics, Inc. 10% Owner 3,104,139
US:ALDX / Aldeyra Therapeutics, Inc. 10% Owner 5,875,851
US:SLDB / Solid Biosciences Inc. Director, 10% Owner 11,833,539
Director, 10% Owner 9,675,684
US:MGTX / MeiraGTx Holdings plc Director, 10% Owner 12,531,103
US:CERE / Cerevel Therapeutics Holdings, Inc. Director 0
US:LIAN / LianBio - Depositary Receipt (Common Stock) Director, 10% Owner 17,082
US:ATXS / Astria Therapeutics, Inc. Director 4,873,721
US:ATHA / Athira Pharma, Inc. Director, 10% Owner 5,402,964
US:VRCA / Verrica Pharmaceuticals Inc. 10% Owner 7,099,182
US:CRGX / CARGO Therapeutics, Inc. 333,333
US:SLNO / Soleno Therapeutics, Inc. 10% Owner 3,074,542
US:LYRA / Lyra Therapeutics, Inc. Director, 10% Owner 11,469,117
US:CEMI / Chembio Diagnostics Inc. 0
US:VBIV / VBI Vaccines Inc. 10% Owner 41,440,729
US:QTNT / Quotient Ltd 10% Owner 7,945,211
US:ALBO / Albireo Pharma Inc 10% Owner 1,939,723
US:CRNX / Crinetics Pharmaceuticals, Inc. 10% Owner 5,321,032
US:NAUT / Nautilus Biotechnology, Inc. 10% Owner 9,111,151
US:AGRX / Agile Therapeutics, Inc. 10% Owner 2,687,280
US:ISO / IsoPlexis Corp 10% Owner 0
10% Owner 2,487,019
US:ADMA / ADMA Biologics, Inc. 10% Owner 13,262,375
US:LPTX / Leap Therapeutics, Inc. 10% Owner 3,508,771
US:LABP / Landos Biopharma, Inc. Director 25,291
US:VYNE / VYNE Therapeutics Inc. 10% Owner 4,935,057
US:RXDX / Prometheus Biosciences Inc 10% Owner 0
US:SCYX / SCYNEXIS, Inc. 10% Owner 2,400,000
US:MOTS / Motus GI Holdings, Inc. 10% Owner 2,660,542
US:ATNX / Athenex Inc 10% Owner 13,532,467
US:KDMN / Kadmon Holdings Inc 10% Owner 14,636,334
US:DOVA / Dova Pharmaceuticals, Inc. 10% Owner 0
US:FOMX / Foamix Pharmaceuticals Ltd. 10% Owner 22,407,762
US:LJPC / La Jolla Pharmaceutical Co. 10% Owner 2,253,376
US:CORI / Corium International, Inc. 10% Owner 2,724,686
US:FOLD / Amicus Therapeutics, Inc. 10% Owner 20,724,424
US:ZGNX / Zogenix Inc 10% Owner 4,070,357
US:GBT / Global Blood Therapeutics Inc. 10% Owner 4,889,066
US:VSAR / Versartis, Inc.. 10% Owner 2,099,563
US:ACRX / Talphera, Inc. 10% Owner 4,533,728
CA: / VBI Vaccines Inc 10% Owner 2,068,824
US:AEGR / Aegerion Pharmaceuticals, Inc. 10% Owner 2,823,426
10% Owner 22,000
US:XTLB / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock) 10% Owner 20,580,260
US:BPA / 10% Owner 209,100
US:AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF 10% Owner 2,700,000
如何解读这些图表

以下图表显示了在Joseph Edelman进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

ACRV / Acrivon Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2024-04-11 ACRV PERCEPTIVE ADVISORS LLC 2,353,000 8.5000 2,353,000 8.5000 20,000,500 7 10.5400 4,800,120 24.00

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ACRV / Acrivon Therapeutics, Inc. Insider Trades
ACRV / Acrivon Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2025-05-01 ACRV PERCEPTIVE ADVISORS LLC 298,886 1.3400 298,886 1.3400 400,507 29 1.0500 -86,677 -21.64
2025-04-30 ACRV PERCEPTIVE ADVISORS LLC 437,881 1.4100 437,881 1.4100 617,412
2025-04-29 ACRV PERCEPTIVE ADVISORS LLC 250,000 1.4100 250,000 1.4100 352,500
2025-04-28 ACRV PERCEPTIVE ADVISORS LLC 215,283 1.5600 215,283 1.5600 335,841
2025-04-25 ACRV PERCEPTIVE ADVISORS LLC 1,054,669 1.9500 1,054,669 1.9500 2,056,605

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ACRV / Acrivon Therapeutics, Inc. Insider Trades
ADMA / ADMA Biologics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2020-03-19 ADMA PERCEPTIVE ADVISORS LLC 500,000 2.1000 500,000 2.1000 1,050,000 133 3.7400 820,000 78.10
2020-02-11 ADMA PERCEPTIVE ADVISORS LLC 4,563,700 3.5000 4,563,700 3.5000 15,972,950
2019-05-21 ADMA PERCEPTIVE ADVISORS LLC 4,000,000 4.0000 4,000,000 4.0000 16,000,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ADMA / ADMA Biologics, Inc. Insider Trades
ADMA / ADMA Biologics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2021-09-30 ADMA PERCEPTIVE ADVISORS LLC 137,495 1.1200 137,495 1.1200 153,994 11 1.09 -4,124 -2.68
2021-09-29 ADMA PERCEPTIVE ADVISORS LLC 82,505 1.1600 82,505 1.1600 95,706
2021-09-28 ADMA PERCEPTIVE ADVISORS LLC 40,603 1.2200 40,603 1.2200 49,536
2021-09-27 ADMA PERCEPTIVE ADVISORS LLC 250,000 1.2300 250,000 1.2300 307,500
2021-09-24 ADMA PERCEPTIVE ADVISORS LLC 250,000 1.2600 250,000 1.2600 315,000
2021-09-23 ADMA PERCEPTIVE ADVISORS LLC 780,000 1.2700 780,000 1.2700 990,600
2021-08-19 ADMA PERCEPTIVE ADVISORS LLC 350,352 1.2400 350,352 1.2400 434,436
2021-08-18 ADMA PERCEPTIVE ADVISORS LLC 552,380 1.2900 552,380 1.2900 712,570
2021-08-17 ADMA PERCEPTIVE ADVISORS LLC 879,092 1.3500 879,092 1.3500 1,186,774

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ADMA / ADMA Biologics, Inc. Insider Trades
AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
ALDX / Aldeyra Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2024-04-05 ALDX PERCEPTIVE ADVISORS LLC 37,712 4.7400 37,712 4.7400 178,755 341 6.9800 84,476 47.26
2024-04-04 ALDX PERCEPTIVE ADVISORS LLC 140,281 4.6700 140,281 4.6700 655,112
2024-04-03 ALDX PERCEPTIVE ADVISORS LLC 309,847 4.0900 309,847 4.0900 1,267,274
2024-04-02 ALDX PERCEPTIVE ADVISORS LLC 186,051 3.4400 186,051 3.4400 640,015
2024-04-01 ALDX PERCEPTIVE ADVISORS LLC 8,374 3.2500 8,374 3.2500 27,216
2022-08-10 ALDX PERCEPTIVE ADVISORS LLC 15,000 7.8500 15,000 7.8500 117,750
2022-08-09 ALDX PERCEPTIVE ADVISORS LLC 100,000 7.5000 100,000 7.5000 750,000
2022-08-08 ALDX PERCEPTIVE ADVISORS LLC 97,000 7.2400 97,000 7.2400 702,280
2022-08-05 ALDX PERCEPTIVE ADVISORS LLC 141,000 6.9500 141,000 6.9500 979,950
2022-08-04 ALDX PERCEPTIVE ADVISORS LLC 95,100 6.1700 95,100 6.1700 586,767
2022-08-03 ALDX PERCEPTIVE ADVISORS LLC 100,000 5.8400 100,000 5.8400 584,000
2022-08-02 ALDX PERCEPTIVE ADVISORS LLC 412,406 5.5900 412,406 5.5900 2,305,350
2022-08-01 ALDX PERCEPTIVE ADVISORS LLC 144,185 5.0500 144,185 5.0500 728,134
2022-07-29 ALDX PERCEPTIVE ADVISORS LLC 222,123 5.0300 222,123 5.0300 1,117,279
2022-07-28 ALDX PERCEPTIVE ADVISORS LLC 119,392 5.0000 119,392 5.0000 596,960
2021-05-03 ALDX PERCEPTIVE ADVISORS LLC 1,200,000 12.5000 1,200,000 12.5000 15,000,000
2021-01-19 ALDX PERCEPTIVE ADVISORS LLC 1,368,421 9.5000 1,368,421 9.5000 13,000,000
2021-01-08 ALDX PERCEPTIVE ADVISORS LLC 347,332 9.2100 347,332 9.2100 3,198,928
2021-01-08 ALDX PERCEPTIVE ADVISORS LLC 152,668 10.2100 152,668 10.2100 1,558,740
2021-01-08 ALDX PERCEPTIVE ADVISORS LLC 50,000 7.6000 50,000 7.6000 380,000
2021-01-07 ALDX PERCEPTIVE ADVISORS LLC 500,000 8.1300 500,000 8.1300 4,065,000
2020-07-09 ALDX PERCEPTIVE ADVISORS LLC 3,200,000 4.2500 3,200,000 4.2500 13,600,000
2017-09-19 ALDX PERCEPTIVE ADVISORS LLC 200,000 7.2500 200,000 7.2500 1,450,000
2017-06-30 ALDX PERCEPTIVE ADVISORS LLC 296,007 4.6000 296,007 4.6000 1,361,632
2017-02-14 ALDX PERCEPTIVE ADVISORS LLC 893,025 4.5000 893,025 4.5000 4,018,612
2016-05-26 ALDX PERCEPTIVE ADVISORS LLC 700,000 5.0000 700,000 5.0000 3,500,000
2015-10-28 ALDX PERCEPTIVE ADVISORS LLC 45,100 6.5000 45,100 6.5000 293,150
2015-10-26 ALDX PERCEPTIVE ADVISORS LLC 50,000 6.4630 50,000 6.4630 323,150
2015-10-22 ALDX PERCEPTIVE ADVISORS LLC 18,020 6.4740 18,020 6.4740 116,661
2015-10-20 ALDX PERCEPTIVE ADVISORS LLC 14,348 6.2960 14,348 6.2960 90,335
2015-10-20 ALDX PERCEPTIVE ADVISORS LLC 22,797 6.4420 22,797 6.4420 146,858

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALDX / Aldeyra Therapeutics, Inc. Insider Trades
ALDX / Aldeyra Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2025-04-03 ALDX PERCEPTIVE ADVISORS LLC 3,400,000 1.4200 3,400,000 1.4200 4,828,000 0 1.4200 0 0.00
2023-10-18 ALDX PERCEPTIVE ADVISORS LLC 306,499 1.7400 306,499 1.7400 533,308
2023-10-16 ALDX PERCEPTIVE ADVISORS LLC 2,450,000 1.6000 2,450,000 1.6000 3,920,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ALDX / Aldeyra Therapeutics, Inc. Insider Trades
ANIP / ANI Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2004-12-02 BPA EDELMAN JOSEPH 2,000 3.9800 2,000 3.9800 7,960 730
2004-10-08 BPA EDELMAN JOSEPH 1,000 9.8652 1,000 9.8652 9,865
2004-10-08 BPA EDELMAN JOSEPH 14,900 9.8652 14,900 9.8652 146,991
2004-10-07 BPA EDELMAN JOSEPH 1,000 10.1071 1,000 10.1071 10,107
2004-10-07 BPA EDELMAN JOSEPH 9,000 10.1071 9,000 10.1071 90,964
2004-10-06 BPA EDELMAN JOSEPH 1,000 9.9013 1,000 9.9013 9,901
2004-10-06 BPA EDELMAN JOSEPH 9,000 9.9013 9,000 9.9013 89,112
2004-10-05 BPA EDELMAN JOSEPH 1,700 9.8998 1,700 9.8998 16,830
2004-10-05 BPA EDELMAN JOSEPH 15,800 9.8998 15,800 9.8998 156,417
2004-10-04 BPA EDELMAN JOSEPH 1,400 9.7207 1,400 9.7207 13,609
2004-10-04 BPA EDELMAN JOSEPH 13,100 9.7207 13,100 9.7207 127,341
2004-10-01 BPA EDELMAN JOSEPH 2,100 9.5900 2,100 9.5900 20,139
2004-10-01 BPA EDELMAN JOSEPH 19,400 9.5900 19,400 9.5900 186,046
2004-09-30 BPA EDELMAN JOSEPH 1,000 8.9645 1,000 8.9645 8,964
2004-09-30 BPA EDELMAN JOSEPH 9,000 8.9645 9,000 8.9645 80,680
2004-09-14 BPA EDELMAN JOSEPH 2,400 7.6852 2,400 7.6852 18,444
2004-09-14 BPA EDELMAN JOSEPH 22,100 7.6852 22,100 7.6852 169,843
2004-09-13 BPA EDELMAN JOSEPH 2,500 7.1681 2,500 7.1681 17,920
2004-09-13 BPA EDELMAN JOSEPH 23,400 7.1681 23,400 7.1681 167,734
2004-09-09 BPA EDELMAN JOSEPH 400 6.8500 400 6.8500 2,740
2004-09-09 BPA EDELMAN JOSEPH 4,300 6.8500 4,300 6.8500 29,455
2004-08-31 BPA EDELMAN JOSEPH 9,000 6.8403 9,000 6.8403 61,563
2004-08-30 BPA EDELMAN JOSEPH 1,000 6.8374 1,000 6.8374 6,837
2004-08-30 BPA EDELMAN JOSEPH 9,000 6.8374 9,000 6.8374 61,537
2004-08-19 BPA EDELMAN JOSEPH 6,200 5.8446 6,200 5.8446 36,237
2004-08-19 BPA EDELMAN JOSEPH 700 5.8446 700 5.8446 4,091
2004-08-18 BPA EDELMAN JOSEPH 40,500 5.8253 40,500 5.8253 235,925
2004-08-18 BPA EDELMAN JOSEPH 4,500 5.8253 4,500 5.8253 26,214
2004-08-16 BPA EDELMAN JOSEPH 200 5.1000 200 5.1000 1,020
2004-08-12 BPA EDELMAN JOSEPH 2,500 4.7500 2,500 4.7500 11,875
2004-08-11 BPA EDELMAN JOSEPH 21,300 4.7175 21,300 4.7175 100,483
2004-08-11 BPA EDELMAN JOSEPH 2,300 4.7175 2,300 4.7175 10,850
2004-07-19 BPA EDELMAN JOSEPH 25,652 5.6747 25,652 5.6747 145,567
2004-07-19 BPA EDELMAN JOSEPH 2,800 5.6747 2,800 5.6747 15,889
2004-07-16 BPA EDELMAN JOSEPH 12,648 5.8877 12,648 5.8877 74,468
2004-07-16 BPA EDELMAN JOSEPH 1,400 5.8870 1,400 5.8870 8,242
2004-07-15 BPA EDELMAN JOSEPH 6,750 5.9633 6,750 5.9633 40,252
2004-07-15 BPA EDELMAN JOSEPH 750 5.9633 750 5.9633 4,472
2004-05-14 BPA EDELMAN JOSEPH 650,000 6.0000 650,000 6.0000 3,900,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
ANIP / ANI Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2004-12-03 BPA EDELMAN JOSEPH 30,000 4.3500 30,000 4.3500 130,500 730
2004-12-03 BPA EDELMAN JOSEPH 50,000 4.5500 50,000 4.5500 227,500
2004-12-03 BPA EDELMAN JOSEPH 1,315,000 4.7150 1,315,000 4.7150 6,200,225
2004-12-02 BPA EDELMAN JOSEPH 28,550 4.4680 28,550 4.4680 127,561
2004-12-02 BPA EDELMAN JOSEPH 70,900 4.4680 70,900 4.4680 316,781
2004-12-02 BPA EDELMAN JOSEPH 25,000 4.9000 25,000 4.9000 122,500
2004-12-02 BPA EDELMAN JOSEPH 2,000 4.4680 2,000 4.4680 8,936
2004-12-02 BPA EDELMAN JOSEPH 273,550 4.4680 273,550 4.4680 1,222,221
2004-08-16 BPA EDELMAN JOSEPH 200 5.5000 200 5.5000 1,100
2004-02-03 BPA EDELMAN JOSEPH 87,400 6.4368 87,400 6.4368 562,576
2004-01-23 BPA EDELMAN JOSEPH 35,000 5.6200 35,000 5.6200 196,700
2004-01-22 BPA EDELMAN JOSEPH 100,000 5.6800 100,000 5.6800 568,000
2004-01-21 BPA EDELMAN JOSEPH 100,000 5.6600 100,000 5.6600 566,000
2004-01-21 BPA EDELMAN JOSEPH 15,000 5.8400 15,000 5.8400 87,600
2004-01-21 BPA EDELMAN JOSEPH 5,000 5.6500 5,000 5.6500 28,250

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
ATHA / Athira Pharma, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2023-12-29 ATHA PERCEPTIVE ADVISORS LLC 163,954 2.3800 163,954 2.3800 390,211 69 4.1500 290,199 74.37
2023-12-28 ATHA PERCEPTIVE ADVISORS LLC 409,598 2.4400 409,598 2.4400 999,419
2023-12-27 ATHA PERCEPTIVE ADVISORS LLC 32,134 2.2800 32,134 2.2800 73,266
2022-06-30 ATHA PERCEPTIVE ADVISORS LLC 1,101,362 2.9900 1,101,362 2.9900 3,293,072
2022-06-29 ATHA PERCEPTIVE ADVISORS LLC 270,000 2.9900 270,000 2.9900 807,300
2021-01-25 ATHA PERCEPTIVE ADVISORS LLC 311,111 22.5000 311,111 22.5000 6,999,998

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATHA / Athira Pharma, Inc. Insider Trades
ATHA / Athira Pharma, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATHA / Athira Pharma, Inc. Insider Trades
ATXS / Astria Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2024-02-01 ATXS PERCEPTIVE ADVISORS LLC 2,481,350 12.0900 2,481,350 12.0900 29,999,522 47 16.6900 11,414,210 38.05
2023-12-21 ATXS PERCEPTIVE ADVISORS LLC 740,000 6.2000 740,000 6.2000 4,588,000
2023-10-16 ATXS PERCEPTIVE ADVISORS LLC 614,062 6.5140 614,062 6.5140 4,000,000
2023-10-16 ATXS PERCEPTIVE ADVISORS LLC 460,546 6.5140 460,546 6.5140 2,999,997
2022-12-19 ATXS PERCEPTIVE ADVISORS LLC 908,265 11.0100 908,265 11.0100 9,999,998

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATXS / Astria Therapeutics, Inc. Insider Trades
ATXS / Astria Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ATXS / Astria Therapeutics, Inc. Insider Trades
CRNX / Crinetics Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2022-04-18 CRNX PERCEPTIVE ADVISORS LLC 157,515 22.2200 157,515 22.2200 3,499,983 2 23.2200 157,515 4.50
2021-10-25 CRNX PERCEPTIVE ADVISORS LLC 1,200,000 19.8000 1,200,000 19.8000 23,760,000
2021-04-08 CRNX PERCEPTIVE ADVISORS LLC 304,136 16.4400 304,136 16.4400 4,999,996
2020-04-17 CRNX PERCEPTIVE ADVISORS LLC 1,071,428 14.0000 1,071,428 14.0000 14,999,992
2018-07-20 CRNX PERCEPTIVE ADVISORS LLC 400,000 17.0000 400,000 17.0000 6,800,000
2018-07-20 CRNX PERCEPTIVE ADVISORS LLC 400,000 17.0000 400,000 17.0000 6,800,000
2018-07-18 CRNX PERCEPTIVE ADVISORS LLC 307,648 21.3000 307,648 21.3000 6,552,902

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

CRNX / Crinetics Pharmaceuticals, Inc. Insider Trades
CRNX / Crinetics Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

CRNX / Crinetics Pharmaceuticals, Inc. Insider Trades
FOLD / Amicus Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2018-10-03 FOLD PERCEPTIVE ADVISORS LLC 30,000 12.6900 30,000 12.6900 380,700 184 14.4 51,300 13.48
2018-09-24 FOLD PERCEPTIVE ADVISORS LLC 20,000 12.4500 20,000 12.4500 249,000
2018-09-21 FOLD PERCEPTIVE ADVISORS LLC 50,000 12.5300 50,000 12.5300 626,500
2018-09-13 FOLD PERCEPTIVE ADVISORS LLC 100,000 11.7400 100,000 11.7400 1,174,000
2018-09-12 FOLD PERCEPTIVE ADVISORS LLC 500,000 12.0030 500,000 12.0030 6,001,500
2018-03-05 FOLD PERCEPTIVE ADVISORS LLC 335,827 13.5600 335,827 13.5600 4,553,814
2018-03-02 FOLD PERCEPTIVE ADVISORS LLC 100,000 13.8950 100,000 13.8950 1,389,500
2018-03-01 FOLD PERCEPTIVE ADVISORS LLC 100,000 13.6900 100,000 13.6900 1,369,000
2017-07-13 FOLD PERCEPTIVE ADVISORS LLC 1,500,000 12.2500 1,500,000 12.2500 18,375,000
2016-12-30 FOLD PERCEPTIVE ADVISORS LLC 94,750 4.9610 94,750 4.9610 470,055
2016-12-29 FOLD PERCEPTIVE ADVISORS LLC 94,750 4.8540 94,750 4.8540 459,916
2016-12-28 FOLD PERCEPTIVE ADVISORS LLC 47,375 4.9120 47,375 4.9120 232,706
2016-12-23 FOLD PERCEPTIVE ADVISORS LLC 47,375 4.7170 47,375 4.7170 223,468
2016-12-23 FOLD PERCEPTIVE ADVISORS LLC 37,900 4.9230 37,900 4.9230 186,582
2016-12-22 FOLD PERCEPTIVE ADVISORS LLC 189,500 4.5110 189,500 4.5110 854,834
2015-10-07 FOLD PERCEPTIVE ADVISORS LLC 50,000 6.2700 50,000 6.2700 313,500
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 86,000 6.6500 86,000 6.6500 571,900
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 86,000 6.4700 86,000 6.4700 556,420
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 43,000 6.3400 43,000 6.3400 272,620
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 14,000 6.6500 14,000 6.6500 93,100
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 14,000 6.4700 14,000 6.4700 90,580
2015-10-06 FOLD PERCEPTIVE ADVISORS LLC 7,000 6.3400 7,000 6.3400 44,380
2015-10-05 FOLD PERCEPTIVE ADVISORS LLC 215,000 6.8500 215,000 6.8500 1,472,750
2015-10-05 FOLD PERCEPTIVE ADVISORS LLC 215,000 6.7600 215,000 6.7600 1,453,400
2015-10-05 FOLD PERCEPTIVE ADVISORS LLC 35,000 6.8500 35,000 6.8500 239,750
2015-10-05 FOLD PERCEPTIVE ADVISORS LLC 35,000 6.7600 35,000 6.7600 236,600
2014-11-19 FOLD PERCEPTIVE ADVISORS LLC 2,100,000 6.5000 2,100,000 6.5000 13,650,000
2014-06-30 FOLD PERCEPTIVE ADVISORS LLC 3,470,000 3.5000 3,470,000 3.5000 12,145,000
2014-06-30 FOLD PERCEPTIVE ADVISORS LLC 530,000 3.5000 530,000 3.5000 1,855,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

FOLD / Amicus Therapeutics, Inc. Insider Trades
FOLD / Amicus Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2016-08-25 FOLD PERCEPTIVE ADVISORS LLC 1,100,000 6.8100 1,100,000 6.8100 7,491,000 119 4.53 -2,508,000 -33.48

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

FOLD / Amicus Therapeutics, Inc. Insider Trades
LPTX / Leap Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2020-06-22 LPTX PERCEPTIVE ADVISORS LLC 1,750,000 2.0000 175,000 20.0000 3,500,000 240 301 49,175,000 1,405.00

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

LPTX / Leap Therapeutics, Inc. Insider Trades
LPTX / Leap Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

LPTX / Leap Therapeutics, Inc. Insider Trades
LYRA / Lyra Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2023-05-31 LYRA PERCEPTIVE ADVISORS LLC 3,610,832 2.4925 72,217 124.6250 8,999,999 301 6.5300 -8,528,428 -94.76
2022-04-12 LYRA PERCEPTIVE ADVISORS LLC 5,924,170 4.2200 118,483 211.0000 24,999,997
2020-05-05 LYRA PERCEPTIVE ADVISORS LLC 625,000 16.0000 12,500 800.0000 10,000,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

LYRA / Lyra Therapeutics, Inc. Insider Trades
LYRA / Lyra Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

LYRA / Lyra Therapeutics, Inc. Insider Trades
MGTX / MeiraGTx Holdings plc内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2024-08-12 MGTX PERCEPTIVE ADVISORS LLC 1,250,000 4.0000 1,250,000 4.0000 5,000,000 336 8.8900 6,112,500 122.25
2023-05-05 MGTX PERCEPTIVE ADVISORS LLC 4,347,826 5.7500 4,347,826 5.7500 25,000,000
2020-11-23 MGTX PERCEPTIVE ADVISORS LLC 500,000 12.8500 500,000 12.8500 6,425,000
2019-08-12 MGTX PERCEPTIVE ADVISORS LLC 425,531 23.5000 425,531 23.5000 9,999,978
2019-03-01 MGTX PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 1,304,348 13.8000 1,304,348 13.8000 18,000,002
2018-06-12 MGTX PERCEPTIVE ADVISORS LLC 1,333,333 15.0000 1,333,333 15.0000 19,999,995
2018-06-08 MGTX PERCEPTIVE ADVISORS LLC 50,000 15.2200 50,000 15.2200 761,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MGTX / MeiraGTx Holdings plc Insider Trades
MGTX / MeiraGTx Holdings plc内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MGTX / MeiraGTx Holdings plc Insider Trades
NAUT / Nautilus Biotechnology, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2021-12-08 NAUT PERCEPTIVE ADVISORS LLC 200,000 5.3600 200,000 5.3600 1,072,000 15 6.04 136,000 12.69
2021-06-09 NAUT PERCEPTIVE ADVISORS LLC 5,500,000 10.0000 5,500,000 10.0000 55,000,000
2021-06-03 ARYA PERCEPTIVE ADVISORS LLC 330,050 10.0500 330,050 10.0500 3,317,002
2021-05-24 NAUT PERCEPTIVE ADVISORS LLC 7,063 10.0500 7,063 10.0500 70,983
2021-05-20 ARYA PERCEPTIVE ADVISORS LLC 159,925 10.0500 159,925 10.0500 1,607,246

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

NAUT / Nautilus Biotechnology, Inc. Insider Trades
NAUT / Nautilus Biotechnology, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

NAUT / Nautilus Biotechnology, Inc. Insider Trades
OBIO / Orchestra BioMed Holdings, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2025-08-01 OBIO PERCEPTIVE ADVISORS LLC 700,000 2.7500 700,000 2.7500 1,925,000 25 3.0000 175,000 9.09

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

OBIO / Orchestra BioMed Holdings, Inc. Insider Trades
OBIO / Orchestra BioMed Holdings, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

OBIO / Orchestra BioMed Holdings, Inc. Insider Trades
SCYX / SCYNEXIS, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SCYX / SCYNEXIS, Inc. Insider Trades
SCYX / SCYNEXIS, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2021-01-22 SCYX PERCEPTIVE ADVISORS LLC 285,151 8.1600 285,151 8.1600 2,326,832 257 4.94 -918,186 -39.46
2021-01-22 SCYX PERCEPTIVE ADVISORS LLC 33,849 8.9500 33,849 8.9500 302,949
2021-01-21 SCYX PERCEPTIVE ADVISORS LLC 95,000 7.3800 95,000 7.3800 701,100
2021-01-20 SCYX PERCEPTIVE ADVISORS LLC 185,000 7.4300 185,000 7.4300 1,374,550

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SCYX / SCYNEXIS, Inc. Insider Trades
SLDB / Solid Biosciences Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2025-02-19 SLDB PERCEPTIVE ADVISORS LLC 5,000,000 4.0300 5,000,000 4.0300 20,150,000 160 7.0700 15,200,000 75.43
2024-01-11 SLDB PERCEPTIVE ADVISORS LLC 3,410,713 5.5300 3,410,713 5.5300 18,861,243
2021-03-23 SLDB PERCEPTIVE ADVISORS LLC 2,608,695 5.7500 173,913 86.2500 14,999,996
2019-07-25 SLDB PERCEPTIVE ADVISORS LLC 2,822,581 4.6500 188,172 69.7500 13,125,002
2018-01-30 SLDB PERCEPTIVE ADVISORS LLC 1,000,000 16.0000 66,667 240.0000 16,000,000
2018-01-30 SLDB PERCEPTIVE ADVISORS LLC 20,000 27.3260 1,333 409.8900 546,520

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLDB / Solid Biosciences Inc. Insider Trades
SLDB / Solid Biosciences Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLDB / Solid Biosciences Inc. Insider Trades
SLNO / Soleno Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2023-09-28 SLNO PERCEPTIVE ADVISORS LLC 250,000 20.0000 250,000 20.0000 5,000,000 356 53.5500 8,387,500 167.75
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 5,703 7.6500 5,703 7.6500 43,628
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 13,687 8.3000 13,687 8.3000 113,602
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 5,419 9.5200 5,419 9.5200 51,589
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 37,911 11.0500 37,911 11.0500 418,917
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 77,837 11.8100 77,837 11.8100 919,255
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 42,838 12.8400 42,838 12.8400 550,040
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 30,511 13.9200 30,511 13.9200 424,713
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 3,326 14.6100 3,326 14.6100 48,593
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 27,769 16.0000 27,769 16.0000 444,304
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 75,477 17.2800 75,477 17.2800 1,304,243
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 52,691 18.2400 52,691 18.2400 961,084
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 88,685 19.1100 88,685 19.1100 1,694,770
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 117,996 20.0300 117,996 20.0300 2,363,460
2023-09-26 SLNO PERCEPTIVE ADVISORS LLC 36,939 21.0000 36,939 21.0000 775,719
2023-06-06 SLNO PERCEPTIVE ADVISORS LLC 200 5.9300 200 5.9300 1,186
2023-06-05 SLNO PERCEPTIVE ADVISORS LLC 78,468 5.9800 78,468 5.9800 469,239
2023-06-02 SLNO PERCEPTIVE ADVISORS LLC 64,630 5.9300 64,630 5.9300 383,256
2023-06-01 SLNO PERCEPTIVE ADVISORS LLC 7,500 5.5900 7,500 5.5900 41,925
2023-05-31 SLNO PERCEPTIVE ADVISORS LLC 10,000 5.2800 10,000 5.2800 52,800
2023-05-30 SLNO PERCEPTIVE ADVISORS LLC 17,500 5.3400 17,500 5.3400 93,450
2023-05-26 SLNO PERCEPTIVE ADVISORS LLC 22,500 5.2700 22,500 5.2700 118,575
2023-05-25 SLNO PERCEPTIVE ADVISORS LLC 37,500 5.1800 37,500 5.1800 194,250
2023-05-24 SLNO PERCEPTIVE ADVISORS LLC 25,000 5.4800 25,000 5.4800 137,000
2023-05-23 SLNO PERCEPTIVE ADVISORS LLC 27,500 5.4500 27,500 5.4500 149,875
2023-05-22 SLNO PERCEPTIVE ADVISORS LLC 27,300 5.1200 27,300 5.1200 139,776
2023-05-19 SLNO PERCEPTIVE ADVISORS LLC 25,200 4.6200 25,200 4.6200 116,424

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLNO / Soleno Therapeutics, Inc. Insider Trades
SLNO / Soleno Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLNO / Soleno Therapeutics, Inc. Insider Trades
TLPH / Talphera, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2013-11-07 ACRX PERCEPTIVE ADVISORS LLC 93,500 6.4981 4,675 129.9620 607,572 118 260.6 610,733 100.52
2013-11-07 ACRX PERCEPTIVE ADVISORS LLC 6,500 6.4981 325 129.9620 42,238
2013-11-06 ACRX PERCEPTIVE ADVISORS LLC 93,500 6.5166 4,675 130.3320 609,302
2013-11-06 ACRX PERCEPTIVE ADVISORS LLC 6,500 6.5166 325 130.3320 42,358
2013-11-04 ACRX PERCEPTIVE ADVISORS LLC 98,175 6.8804 4,909 137.6080 675,483
2013-11-04 ACRX PERCEPTIVE ADVISORS LLC 6,825 6.8804 341 137.6080 46,959
2013-11-04 ACRX PERCEPTIVE ADVISORS LLC 46,750 6.8370 2,338 136.7400 319,630
2013-11-04 ACRX PERCEPTIVE ADVISORS LLC 3,250 6.8370 162 136.7400 22,220
2013-11-01 ACRX PERCEPTIVE ADVISORS LLC 10,442 7.1698 522 143.3960 74,867
2013-11-01 ACRX PERCEPTIVE ADVISORS LLC 150,218 7.1698 7,511 143.3960 1,077,033
2013-10-31 ACRX PERCEPTIVE ADVISORS LLC 192,000 6.6932 9,600 133.8640 1,285,094
2013-10-31 ACRX PERCEPTIVE ADVISORS LLC 8,000 6.6932 400 133.8640 53,546
2013-07-23 ACRX PERCEPTIVE ADVISORS LLC 850,000 11.6500 42,500 233.0000 9,902,500

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TLPH / Talphera, Inc. Insider Trades
TLPH / Talphera, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2017-06-19 ACRX PERCEPTIVE ADVISORS LLC 875,000 2.4000 43,750 48.0000 2,100,000 235 34 -612,500 -29.17
2016-09-29 ACRX PERCEPTIVE ADVISORS LLC 97,200 3.8798 4,860 77.5960 377,117
2016-09-28 ACRX PERCEPTIVE ADVISORS LLC 119,300 3.9596 5,965 79.1920 472,380
2016-09-15 ACRX PERCEPTIVE ADVISORS LLC 276,927 3.7277 13,846 74.5540 1,032,301
2016-09-15 ACRX PERCEPTIVE ADVISORS LLC 115,923 3.6275 5,796 72.5500 420,511
2015-11-18 ACRX PERCEPTIVE ADVISORS LLC 42,300 5.3459 2,115 106.9180 226,132
2015-11-17 ACRX PERCEPTIVE ADVISORS LLC 133,900 5.3578 6,695 107.1560 717,409
2015-11-06 ACRX PERCEPTIVE ADVISORS LLC 17,100 4.4658 855 89.3160 76,365
2015-11-05 ACRX PERCEPTIVE ADVISORS LLC 75,000 4.6168 3,750 92.3360 346,260
2015-09-09 ACRX PERCEPTIVE ADVISORS LLC 310,000 4.1767 15,500 83.5340 1,294,777

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

TLPH / Talphera, Inc. Insider Trades
VRCA / Verrica Pharmaceuticals Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2023-12-29 VRCA PERCEPTIVE ADVISORS LLC 115,774 7.2400 11,577 72.4000 838,204 136 9.5600 -727,527 -86.80
2023-12-28 VRCA PERCEPTIVE ADVISORS LLC 126,116 7.0800 12,612 70.8000 892,901
2023-12-27 VRCA PERCEPTIVE ADVISORS LLC 79,726 7.2000 7,973 72.0000 574,027
2023-12-26 VRCA PERCEPTIVE ADVISORS LLC 54,652 6.4900 5,465 64.9000 354,691
2023-12-22 VRCA PERCEPTIVE ADVISORS LLC 250,000 6.6700 25,000 66.7000 1,667,500
2023-12-21 VRCA PERCEPTIVE ADVISORS LLC 200,000 6.1700 20,000 61.7000 1,234,000
2023-12-19 VRCA PERCEPTIVE ADVISORS LLC 277,008 5.3600 27,701 53.6000 1,484,763
2023-12-18 VRCA PERCEPTIVE ADVISORS LLC 456,923 5.4100 45,692 54.1000 2,471,953
2023-12-15 VRCA PERCEPTIVE ADVISORS LLC 500,000 5.9700 50,000 59.7000 2,985,000
2022-07-05 VRCA PERCEPTIVE ADVISORS LLC 1,428,571 2.1000 142,857 21.0000 2,999,999
2018-06-19 VRCA PERCEPTIVE ADVISORS LLC 1,000,000 15.0000 100,000 150.0000 15,000,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

VRCA / Verrica Pharmaceuticals Inc. Insider Trades
VRCA / Verrica Pharmaceuticals Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

VRCA / Verrica Pharmaceuticals Inc. Insider Trades
VYNE / VYNE Therapeutics Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2021-01-28 VYNE PERCEPTIVE ADVISORS LLC 4,219,409 2.3700 383,583 26.0700 9,999,999 19 182.16 59,873,298 598.73
2020-06-09 MNLO PERCEPTIVE ADVISORS LLC 2,702,702 1.8500 245,700 20.3500 4,999,999

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

VYNE / VYNE Therapeutics Inc. Insider Trades
VYNE / VYNE Therapeutics Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ACRV / Acrivon Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2021-08-16 VYNE PERCEPTIVE ADVISORS LLC 250,000 1.7400 13,889 31.3200 435,000 360 5.472 -359,005 -82.53
2021-08-13 VYNE PERCEPTIVE ADVISORS LLC 250,000 1.8400 13,889 33.1200 460,000
2021-08-12 VYNE PERCEPTIVE ADVISORS LLC 338,897 2.2300 18,828 40.1400 755,740
2021-05-06 VYNE PERCEPTIVE ADVISORS LLC 1,000,000 3.6700 55,556 66.0600 3,670,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

VYNE / VYNE Therapeutics Inc. Insider Trades
内幕交易历史

该表格显示了由 Joseph Edelman 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2025-08-05 2025-08-01 4 OBIO Orchestra BioMed Holdings, Inc.
Common Stock 		P - Purchase 700,000 5,292,556 15.24 2.75 1,925,000 14,554,529
2025-05-01 2025-05-01 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		S - Sale -298,886 3,104,139 -8.78 1.34 -400,507 4,159,546
2025-05-01 2025-04-30 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		S - Sale -437,881 3,403,025 -11.40 1.41 -617,412 4,798,265
2025-04-29 2025-04-29 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		S - Sale -250,000 3,840,906 -6.11 1.41 -352,500 5,415,677
2025-04-29 2025-04-28 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		S - Sale -215,283 4,090,906 -5.00 1.56 -335,841 6,381,813
2025-04-29 2025-04-25 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		S - Sale -1,054,669 4,306,189 -19.67 1.95 -2,056,605 8,397,069
2025-04-07 2025-04-03 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		S - Sale -3,400,000 5,875,851 -36.65 1.42 -4,828,000 8,343,708
2025-02-21 2025-02-19 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 5,000,000 11,833,539 73.17 4.03 20,150,000 47,689,162
2025-02-14 2025-01-22 4 ADGM Adagio Medical Holdings, Inc.
Common Stock 		A - Award 64,167 9,675,684 0.67
2024-08-14 2024-08-12 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 1,250,000 12,531,103 11.08 4.00 5,000,000 50,124,412
2024-08-01 3 ADGM Adagio Medical Holdings, Inc.
Common stock 		7,160,397
2024-07-17 3 OBIO Orchestra BioMed Holdings, Inc.
Common Stock, $0.0001 par value per share 		4,592,556
2024-04-15 2024-04-11 4 ACRV Acrivon Therapeutics, Inc.
Common Stock 		P - Purchase 2,353,000 5,360,858 78.23 8.50 20,000,500 45,567,293
2024-04-08 2024-04-05 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 37,712 9,275,851 0.41 4.74 178,755 43,967,534
2024-04-08 2024-04-04 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 140,281 9,238,139 1.54 4.67 655,112 43,142,109
2024-04-03 2024-04-03 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 309,847 9,097,858 3.53 4.09 1,267,274 37,210,239
2024-04-03 2024-04-02 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 186,051 8,788,011 2.16 3.44 640,015 30,230,758
2024-04-03 2024-04-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 8,374 8,601,960 0.10 3.25 27,216 27,956,370
2024-02-21 2024-02-20 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		G - Gift -170,317 0 -100.00
2024-02-20 2024-02-15 4 LIAN LianBio
Ordinary Shares 		F - Taxes -19,218 17,082 -52.94 4.76 -91,478 81,310
2024-02-20 2024-02-15 4 LIAN LianBio
Ordinary Shares 		F - Taxes -19,218 17,082 -52.94 4.76 -91,478 81,310
2024-02-20 2024-02-15 4 LIAN LianBio
Ordinary Shares 		M - Exercise 36,300 36,300 2.52 91,476 91,476
2024-02-20 2024-02-15 4 LIAN LianBio
Ordinary Shares 		M - Exercise 36,300 36,300 2.52 91,476 91,476
2024-02-05 2024-02-01 4 ATXS Astria Therapeutics, Inc.
Common Stock 		P - Purchase 2,481,350 4,873,721 103.72 12.09 29,999,522 58,923,287
2024-01-12 2024-01-11 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 3,410,713 6,833,539 99.65 5.53 18,861,243 37,789,471
2023-12-29 2023-12-29 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 163,954 5,402,964 3.13 2.38 390,211 12,859,054
2023-12-29 2023-12-28 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 409,598 5,239,010 8.48 2.44 999,419 12,783,184
2023-12-29 2023-12-27 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 32,134 4,829,412 0.67 2.28 73,266 11,011,059
2023-12-29 2023-12-29 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 115,774 7,099,182 1.66 7.24 838,204 51,398,078
2023-12-29 2023-12-28 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 126,116 6,983,408 1.84 7.08 892,901 49,442,529
2023-12-29 2023-12-27 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 79,726 6,857,292 1.18 7.20 574,027 49,372,502
2023-12-26 2023-12-26 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 54,652 6,777,566 0.81 6.49 354,691 43,986,403
2023-12-26 2023-12-22 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 250,000 6,722,914 3.86 6.67 1,667,500 44,841,836
2023-12-26 2023-12-21 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 200,000 6,472,914 3.19 6.17 1,234,000 39,937,879
2023-12-22 2023-12-21 4 ATXS Astria Therapeutics, Inc.
Common Stock 		P - Purchase 740,000 2,392,371 44.78 6.20 4,588,000 14,832,700
2023-12-19 2023-12-19 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 277,008 6,272,914 4.62 5.36 1,484,763 33,622,819
2023-12-19 2023-12-18 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 456,923 5,995,906 8.25 5.41 2,471,953 32,437,851
2023-12-19 2023-12-15 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 500,000 5,538,983 9.92 5.97 2,985,000 33,067,729
2023-11-14 2023-11-14 4 CRGX CARGO Therapeutics, Inc.
Common Stock 		P - Purchase 333,333 333,333 15.00 4,999,995 4,999,995
2023-11-14 2023-11-14 4 CRGX CARGO Therapeutics, Inc.
Common Stock 		P - Purchase 333,333 333,333 15.00 4,999,995 4,999,995
2023-11-14 2023-11-14 4 CRGX CARGO Therapeutics, Inc.
Common Stock 		C - Conversion 2,579,502 2,579,502
2023-10-18 2023-10-16 4 ATXS Astria Therapeutics, Inc.
Common Stock 		P - Purchase 460,546 1,611,699 40.01 6.51 2,999,997 10,498,607
2023-10-18 2023-10-16 4 ATXS Astria Therapeutics, Inc.
Common Stock 		P - Purchase 614,062 1,652,371 59.14 6.51 4,000,000 10,763,545
2023-10-18 2023-10-18 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		S - Sale -306,499 8,593,586 -3.44 1.74 -533,308 14,952,840
2023-10-18 2023-10-16 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		S - Sale -2,450,000 8,900,085 -21.59 1.60 -3,920,000 14,240,136
2023-10-17 2023-10-16 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 876,808 10,794,876 8.84 22.81 19,999,990 246,231,122
2023-09-28 2023-09-28 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 250,000 3,074,542 8.85 20.00 5,000,000 61,490,840
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 36,939 2,824,542 1.33 21.00 775,719 59,315,382
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 117,996 2,787,603 4.42 20.03 2,363,460 55,835,688
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 88,685 2,669,607 3.44 19.11 1,694,770 51,016,190
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 52,691 2,580,922 2.08 18.24 961,084 47,076,017
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 75,477 2,528,231 3.08 17.28 1,304,243 43,687,832
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 27,769 2,452,754 1.15 16.00 444,304 39,244,064
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 3,326 2,424,985 0.14 14.61 48,593 35,429,031
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 30,511 2,421,659 1.28 13.92 424,713 33,709,493
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 42,838 2,391,148 1.82 12.84 550,040 30,702,340
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 77,837 2,348,310 3.43 11.81 919,255 27,733,541
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 37,911 2,270,473 1.70 11.05 418,917 25,088,727
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 5,419 2,232,562 0.24 9.52 51,589 21,253,990
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 13,687 2,227,143 0.62 8.30 113,602 18,485,287
2023-09-28 2023-09-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 5,703 2,213,456 0.26 7.65 43,628 16,932,938
2023-06-06 2023-06-06 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 200 2,207,753 0.01 5.93 1,186 13,091,975
2023-06-06 2023-06-05 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 78,468 2,207,553 3.69 5.98 469,239 13,201,167
2023-06-06 2023-06-02 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 64,630 2,129,085 3.13 5.93 383,256 12,625,474
2023-06-02 2023-05-31 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		P - Purchase 3,610,832 11,469,117 45.95 2.49 8,999,999 28,586,774
2023-06-01 2023-06-01 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 7,500 2,064,455 0.36 5.59 41,925 11,540,303
2023-06-01 2023-05-31 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 10,000 2,056,955 0.49 5.28 52,800 10,860,722
2023-06-01 2023-05-30 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 17,500 2,046,955 0.86 5.34 93,450 10,930,740
2023-05-26 2023-05-26 4 SLNO SOLENO THERAPEUTICS INC
210859 		P - Purchase 22,500 2,029,455 1.12 5.27 118,575 10,695,228
2023-05-26 2023-05-25 4 SLNO SOLENO THERAPEUTICS INC
210859 		P - Purchase 37,500 2,006,955 1.90 5.18 194,250 10,396,027
2023-05-26 2023-05-24 4 SLNO SOLENO THERAPEUTICS INC
210859 		P - Purchase 25,000 1,969,455 1.29 5.48 137,000 10,792,613
2023-05-23 2023-05-23 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 27,500 1,944,455 1.43 5.45 149,875 10,597,280
2023-05-23 2023-05-22 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 27,300 1,916,955 1.44 5.12 139,776 9,814,810
2023-05-23 2023-05-19 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 25,200 1,889,655 1.35 4.62 116,424 8,730,206
2023-05-18 3 SLNO SOLENO THERAPEUTICS INC
Common Stock 		1,864,455
2023-05-15 2023-05-05 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 4,347,826 11,281,103 62.71 5.75 25,000,000 64,866,342
2023-05-01 2023-04-27 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		U - Other -5,162,782 0 -100.00 0.45 -2,323,252
2023-04-25 2023-04-25 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 133,742 5,162,782 2.66 0.45 60,184 2,323,252
2023-04-25 2023-04-24 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 39,506 5,029,040 0.79 0.45 17,778 2,263,068
2023-04-25 2023-04-21 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 70,200 4,989,534 1.43 0.45 31,450 2,235,311
2023-04-20 2023-04-20 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 56,000 4,919,334 1.15 0.45 25,200 2,213,700
2023-04-20 2023-04-19 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 137,000 4,863,334 2.90 0.45 61,376 2,178,774
2023-04-20 2023-04-18 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 15,800 4,726,334 0.34 0.45 7,078 2,117,398
2023-04-17 2023-04-17 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 4,800 4,710,534 0.10 0.45 2,160 2,119,740
2023-04-17 2023-04-14 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 11,500 4,705,734 0.24 0.45 5,175 2,117,580
2023-04-17 2023-04-13 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 140,134 4,694,234 3.08 0.45 63,060 2,112,405
2023-04-13 2023-04-11 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 129,000 4,554,100 2.92 0.44 56,760 2,003,804
2023-04-06 2023-04-06 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -4,251,563 41,440,729 -9.30 0.11 -467,672 4,558,480
2023-04-06 2023-04-05 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -1,832,563 45,691,816 -3.86 0.13 -238,233 5,939,936
2023-04-06 2023-04-04 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -4,810,623 47,524,379 -9.19 0.16 -769,700 7,603,901
2023-04-06 3 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		3,672,662
2023-04-06 2023-04-06 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 339,000 4,425,100 8.30 0.44 149,160 1,947,044
2023-04-06 2023-04-05 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 217,500 4,086,100 5.62 0.45 97,875 1,838,745
2023-04-06 2023-04-04 4 CEMI CHEMBIO DIAGNOSTICS, INC.
Common Stock 		P - Purchase 195,938 3,868,600 5.34 0.44 86,213 1,702,184
2022-12-21 2022-12-19 4 ATXS Astria Therapeutics, Inc.
Common Stock 		P - Purchase 908,265 1,038,309 698.43 11.01 9,999,998 11,431,782
2022-12-06 2022-12-02 4 SLDB Solid Biosciences Inc.
Common Stock 		A - Award 73,107 73,107
2022-12-06 2022-12-02 4 SLDB Solid Biosciences Inc.
Common Stock 		A - Award 365,536 3,422,826 11.96
2022-12-06 2022-12-02 4 SLDB Solid Biosciences Inc.
Common Stock 		A - Award 2,163,120 3,057,290 241.91 7.05 15,249,996 21,553,894
2022-11-18 3 ACRV Acrivon Therapeutics, Inc.
Common Stock 		3,007,858
2022-11-02 2022-10-31 4 QTNT Quotient Ltd
Ordinary Shares, nil par value 		S - Sale -8,255,607 7,945,211 -50.96 0.08 -660,449 635,617
2022-10-13 2022-10-13 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -406 1,939,723 -0.02 22.79 -9,253 44,206,287
2022-10-13 2022-10-13 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -178,726 1,940,129 -8.44 22.01 -3,933,759 42,702,239
2022-10-13 2022-10-12 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -7,240 2,118,855 -0.34 23.23 -168,185 49,221,002
2022-10-13 2022-10-12 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -89,979 2,126,095 -4.06 22.26 -2,002,933 47,326,875
2022-10-13 2022-10-11 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -5,415 2,216,074 -0.24 24.78 -134,184 54,914,314
2022-10-13 2022-10-11 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -38,310 2,221,489 -1.70 24.18 -926,336 53,715,604
2022-10-13 2022-10-11 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		S - Sale -100,340 2,259,799 -4.25 23.23 -2,330,898 52,495,131
2022-08-22 2022-08-18 4 LIAN LianBio
American Depositary Shares 		P - Purchase 998,240 3,728,491 36.56 2.40 2,395,776 8,948,378
2022-08-18 2022-08-16 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 1,425,000 6,511,727 28.01 35.00 49,875,000 227,910,445
2022-08-11 2022-08-10 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 15,000 11,350,085 0.13 7.85 117,750 89,098,167
2022-08-11 2022-08-09 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 100,000 11,335,085 0.89 7.50 750,000 85,013,138
2022-08-10 2022-08-08 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 97,000 11,235,085 0.87 7.24 702,280 81,342,015
2022-08-09 2022-08-05 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 141,000 11,138,085 1.28 6.95 979,950 77,409,691
2022-08-08 2022-08-04 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 95,100 10,997,085 0.87 6.17 586,767 67,852,014
2022-08-05 2022-08-03 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 100,000 10,901,985 0.93 5.84 584,000 63,667,592
2022-08-04 2022-08-02 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 412,406 10,801,985 3.97 5.59 2,305,350 60,383,096
2022-08-03 2022-08-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 144,185 10,389,579 1.41 5.05 728,134 52,467,374
2022-08-02 2022-07-29 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 222,123 10,245,394 2.22 5.03 1,117,279 51,534,332
2022-08-01 2022-07-28 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 119,392 10,023,271 1.21 5.00 596,960 50,116,355
2022-07-05 2022-07-05 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 1,428,571 5,038,983 39.57 2.10 2,999,999 10,581,864
2022-07-01 2022-06-30 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 1,101,362 4,797,278 29.80 2.99 3,293,072 14,343,861
2022-07-01 2022-06-29 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 270,000 3,695,916 7.88 2.99 807,300 11,050,789
2022-05-27 2022-05-26 4 LIAN LianBio
American Depositary Shares 		P - Purchase 69,000 2,730,251 2.59 3.13 215,970 8,545,686
2022-05-27 2022-05-20 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy) 		A - Award 13,871 13,871
2022-05-25 2022-05-25 4 LIAN LianBio
American Depositary Shares 		P - Purchase 120,000 2,661,251 4.72 2.63 315,600 6,999,090
2022-05-25 2022-05-24 4 LIAN LianBio
American Depositary Shares 		P - Purchase 42,551 2,541,251 1.70 2.47 105,101 6,276,890
2022-05-25 2022-05-23 4 LIAN LianBio
American Depositary Shares 		P - Purchase 8,700 2,498,700 0.35 2.49 21,663 6,221,763
2022-04-18 2022-04-18 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 157,515 5,321,032 3.05 22.22 3,499,983 118,233,331
2022-04-14 2022-04-12 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		P - Purchase 5,924,170 7,858,285 306.30 4.22 24,999,997 33,161,963
2021-12-10 2021-12-08 4 NAUT Nautilus Biotechnology, Inc.
Common Stock 		P - Purchase 200,000 9,111,151 2.24 5.36 1,072,000 48,835,769
2021-12-03 2021-12-01 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -2,707,463 52,334,993 -4.92 3.31 -8,961,703 173,228,827
2021-11-05 2021-11-03 4 LIAN LianBio
Ordinary Shares 		P - Purchase 20,000 27,858,895 0.07 13.51 270,200 376,373,671
2021-11-05 2021-11-03 4 LIAN LianBio
Ordinary Shares 		P - Purchase 2,250,000 27,838,895 8.79 16.00 36,000,000 445,422,320
2021-11-03 2021-11-03 4 LIAN LianBio
Series A Preferred Shares 		C - Conversion -423,579 0 -100.00
2021-11-03 2021-11-03 4 LIAN LianBio
Series Seed Preferred Shares 		C - Conversion -500,000 0 -100.00
2021-11-03 2021-11-03 4 LIAN LianBio
Series Seed Preferred Shares 		C - Conversion -2,500,000 0 -100.00
2021-11-03 2021-11-03 4 LIAN LianBio
Series Seed Preferred Shares 		C - Conversion -2,500,000 0 -100.00
2021-11-03 2021-11-03 4 LIAN LianBio
Series A Preferred Shares 		C - Conversion -635,369 0 -100.00
2021-11-03 2021-11-03 4 LIAN LianBio
Ordinary Shares 		C - Conversion 2,477,005 2,477,005
2021-11-03 2021-11-03 4 LIAN LianBio
Ordinary Shares 		C - Conversion 2,923,000 4,330,675 207.65
2021-11-03 2021-11-03 4 LIAN LianBio
Ordinary Shares 		C - Conversion 14,619,500 21,653,385 207.84
2021-11-03 2021-11-03 4 LIAN LianBio
Ordinary Shares 		C - Conversion 14,619,500 21,653,385 207.84
2021-11-03 2021-11-03 4 LIAN LianBio
Ordinary Shares 		C - Conversion 3,715,510 10,969,395 51.22
2021-11-03 2021-11-02 4 LIAN LianBio
Ordinary Shares 		P - Purchase 100,000 7,253,885 1.40 13.50 1,350,000 97,927,448
2021-11-03 2021-11-01 4 LIAN LianBio
Ordinary Shares 		P - Purchase 120,000 7,153,885 1.71 15.50 1,860,000 110,885,218
2021-10-29 3 LIAN LianBio
Ordinary Shares 		7,033,885
2021-10-29 3 LIAN LianBio
Ordinary Shares 		7,033,885
2021-10-29 3 LIAN LianBio
Ordinary Shares 		1,406,775
2021-10-25 2021-10-25 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 1,200,000 5,163,517 30.28 19.80 23,760,000 102,237,637
2021-10-15 2021-10-13 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy) 		P - Purchase 2,687,280 2,687,280
2021-10-15 2021-10-13 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 5,734,560 21,654,485 36.02 0.85 4,874,376 18,406,312
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Series D Redeemable Convertible Preferred Stock 		C - Conversion -24,629 0 -100.00
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Series D Redeemable Convertible Preferred Stock 		C - Conversion -40,373 0 -100.00
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Series D Redeemable Convertible Preferred Stock 		C - Conversion -325,014 0 -100.00
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Common Stock 		P - Purchase 850,000 3,554,587 31.43 15.00 12,750,000 53,318,805
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Common Stock 		C - Conversion 204,949 204,949
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Common Stock 		C - Conversion 335,962 335,962
2021-10-14 2021-10-12 4 ISO IsoPlexis Corp
Common Stock 		C - Conversion 2,704,587 2,704,587
2021-10-13 2021-10-12 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -7,306 2,487,019 -0.29 13.40 -97,900 33,326,055
2021-10-13 2021-10-11 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -9,351 2,494,325 -0.37 13.15 -122,966 32,800,374
2021-10-13 2021-10-11 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -12,475 2,503,676 -0.50 12.03 -150,074 30,119,222
2021-10-13 2021-10-08 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -2,462 2,516,151 -0.10 13.66 -33,631 34,370,623
2021-10-13 2021-10-08 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -5,038 2,518,613 -0.20 12.90 -64,990 32,490,108
2021-10-13 2021-10-07 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -286 2,523,651 -0.01 15.05 -4,304 37,980,948
2021-10-13 2021-10-07 4 RAIN Rain Therapeutics Inc.
Common Stock 		S - Sale -13,082 2,523,937 -0.52 14.80 -193,614 37,354,268
2021-09-30 2021-09-30 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -137,495 13,262,375 -1.03 1.12 -153,994 14,853,860
2021-09-30 2021-09-29 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -82,505 13,399,870 -0.61 1.16 -95,706 15,543,849
2021-09-30 2021-09-28 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -40,603 13,482,375 -0.30 1.22 -49,536 16,448,498
2021-09-29 2021-09-27 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -250,000 13,522,978 -1.82 1.23 -307,500 16,633,263
2021-09-29 2021-09-24 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -250,000 13,772,978 -1.78 1.26 -315,000 17,353,952
2021-09-28 2021-09-24 4 LPTX LEAP THERAPEUTICS, INC.
Warrants (right to buy) 		P - Purchase 3,508,771 3,508,771 2.85 9,996,489 9,996,489
2021-09-28 2021-09-23 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -780,000 14,022,978 -5.27 1.27 -990,600 17,809,182
2021-08-31 2021-08-26 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 68,047 5,086,727 1.36 30.23 2,057,061 153,771,757
2021-08-31 2021-08-27 4 LABP Landos Biopharma, Inc.
Stock Option (Right to Buy) 		A - Award 25,291 25,291
2021-08-25 2021-08-25 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 61,387 5,018,680 1.24 28.57 1,753,827 143,383,688
2021-08-25 2021-08-24 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 69,761 4,957,293 1.43 27.73 1,934,473 137,465,735
2021-08-25 2021-08-23 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 44,437 4,887,532 0.92 25.78 1,145,586 126,000,575
2021-08-19 2021-08-19 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -350,352 14,802,978 -2.31 1.24 -434,436 18,355,693
2021-08-19 2021-08-18 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -552,380 15,153,330 -3.52 1.29 -712,570 19,547,796
2021-08-19 2021-08-17 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		S - Sale -879,092 15,705,710 -5.30 1.35 -1,186,774 21,202,708
2021-08-18 2021-08-16 4 VYNE VYNE Therapeutics Inc.
Common Stock 		S - Sale -250,000 4,935,057 -4.82 1.74 -435,000 8,586,999
2021-08-17 2021-08-13 4 VYNE VYNE Therapeutics Inc.
Common Stock 		S - Sale -250,000 5,185,057 -4.60 1.84 -460,000 9,540,505
2021-08-16 2021-08-12 4 VYNE VYNE Therapeutics Inc.
Common Stock 		S - Sale -338,897 5,435,057 -5.87 2.23 -755,740 12,120,177
2021-07-09 2021-07-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock 		P - Purchase 200,000 4,843,095 4.31 25.00 5,000,000 121,077,375
2021-06-30 2021-06-29 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -145,548 0 -100.00 3.80 -553,082
2021-06-30 2021-06-29 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -500,709 0 -100.00 3.80 -1,902,694
2021-06-14 2021-06-10 4 MGTX MeiraGTx Holdings plc
Stock Option (right to buy) 		A - Award 15,000 15,000
2021-06-14 2021-06-10 4 MGTX MeiraGTx Holdings plc
Restricted Share Units 		A - Award 15,000 15,000
2021-06-11 2021-06-09 4 NAUT Nautilus Biotechnology, Inc.
Common Stock 		J - Other 2,914,113 8,911,151 48.59
2021-06-11 2021-06-09 4 NAUT Nautilus Biotechnology, Inc.
Common Stock 		P - Purchase 5,500,000 5,997,038 1,106.56 10.00 55,000,000 59,970,380
2021-06-11 2021-05-24 4 NAUT Nautilus Biotechnology, Inc.
Common Stock 		P - Purchase 7,063 497,038 1.44 10.05 70,983 4,995,232
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Warrant (right to buy) 		X - Other -465,936 0 -100.00
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Warrant (right to buy) 		X - Other -1,602,888 0 -100.00
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -320,388 145,548 -68.76 4.00 -1,281,552 582,192
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Common Stock 		S - Sale -1,102,179 500,709 -68.76 4.00 -4,408,716 2,002,836
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Common Stock 		X - Other 465,936 465,936 2.75 1,281,324 1,281,324
2021-06-11 2021-06-09 4 VBIV VBI Vaccines Inc/BC
Common Stock 		X - Other 1,602,888 1,602,888 2.75 4,407,942 4,407,942
2021-06-03 2021-06-03 4 ARYA ARYA Sciences Acquisition Corp III
Class A Ordinary Shares 		P - Purchase 330,050 489,975 206.38 10.05 3,317,002 4,924,249
2021-06-01 2021-05-28 4 ATHA Athira Pharma, Inc.
Stock Option (Right to Buy) 		A - Award 13,871 13,871
2021-05-24 2021-05-20 4 ARYA ARYA Sciences Acquisition Corp III
Class A Ordinary Shares 		P - Purchase 159,925 159,925 10.05 1,607,246 1,607,246
2021-05-07 2021-05-06 4 VYNE VYNE Therapeutics Inc.
Common Stock 		S - Sale -1,000,000 5,773,954 -14.76 3.67 -3,670,000 21,190,411
2021-05-04 2021-05-03 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 1,200,000 9,903,879 13.79 12.50 15,000,000 123,798,488
2021-04-27 2021-04-27 4 RAIN Rain Therapeutics Inc.
Series B Convertible Preferred Stock 		C - Conversion -1,195,792 0 -100.00
2021-04-27 2021-04-27 4 RAIN Rain Therapeutics Inc.
Series A Convertible Preferred Stock 		C - Conversion -949,992 0 -100.00
2021-04-27 2021-04-27 4 RAIN Rain Therapeutics Inc.
Common Stock 		P - Purchase 550,000 2,537,019 27.68 17.00 9,350,000 43,129,323
2021-04-27 2021-04-27 4 RAIN Rain Therapeutics Inc.
Common Stock 		C - Conversion 1,107,316 1,987,019 125.87
2021-04-27 2021-04-27 4 RAIN Rain Therapeutics Inc.
Common Stock 		C - Conversion 879,703 879,703
2021-04-09 2021-04-08 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 304,136 3,963,517 8.31 16.44 4,999,996 65,160,219
2021-04-06 2021-02-26 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy) 		J - Other 450,000 450,000
2021-03-23 2021-03-23 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 2,608,695 13,412,552 24.15 5.75 14,999,996 77,122,174
2021-03-16 2021-03-16 4 RXDX Prometheus Biosciences, Inc.
Series D-2 Convertible Preferred Stock 		C - Conversion -14,462,623 0 -100.00
2021-03-16 2021-03-16 4 RXDX Prometheus Biosciences, Inc.
Series D-1 Convertible Preferred Stock 		C - Conversion -10,177,703 0 -100.00
2021-03-16 2021-03-16 4 RXDX Prometheus Biosciences, Inc.
Common Stock 		P - Purchase 850,000 3,314,032 34.50 19.00 16,150,000 62,966,608
2021-03-16 2021-03-16 4 RXDX Prometheus Biosciences, Inc.
Common Stock 		C - Conversion 1,446,262 2,464,032 142.10
2021-03-16 2021-03-16 4 RXDX Prometheus Biosciences, Inc.
Common Stock 		C - Conversion 1,017,770 1,017,770
2021-02-09 2021-02-09 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 34,951 7,299,751 0.48 14.60 510,285 106,576,365
2021-02-09 2021-02-09 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 64,730 7,264,800 0.90 13.80 893,274 100,254,240
2021-02-09 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 1,771 7,200,070 0.02 13.10 23,200 94,320,917
2021-02-09 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 86,671 7,198,299 1.22 12.53 1,085,988 90,194,686
2021-02-09 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 34,611 7,111,628 0.49 11.38 393,873 80,930,327
2021-02-09 2021-02-05 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 27,453 7,077,017 0.39 11.14 305,826 78,837,969
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Series B Preferred Stock 		C - Conversion -1,770,600 0 -100.00
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Series B Preferred Stock 		C - Conversion -2,857,795 0 -100.00
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Series B Preferred Stock 		C - Conversion -2,857,795 0 -100.00
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Series A Preferred Stock 		C - Conversion -2,941,769 0 -100.00
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Series A Preferred Stock 		C - Conversion -2,941,769 0 -100.00
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		P - Purchase 1,250,000 7,049,564 21.55 16.00 20,000,000 112,793,024
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		C - Conversion 1,770,600 1,770,600
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		C - Conversion 2,857,795 5,799,564 97.15
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		C - Conversion 2,857,795 5,799,564 97.15
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		C - Conversion 2,941,769 2,941,769
2021-02-08 2021-02-08 4 LABP Landos Biopharma, Inc.
Common Stock 		C - Conversion 2,941,769 2,941,769
2021-02-03 3 LABP Landos Biopharma, Inc.
Common Stock 		3,090,924
2021-02-03 3 CATB CATABASIS PHARMACEUTICALS INC
Common Stock 		543,373
2021-02-03 3 CATB CATABASIS PHARMACEUTICALS INC
Common Stock 		1,933,551
2021-02-03 2021-02-01 4 CATB CATABASIS PHARMACEUTICALS INC
Series X Convertible Preferred Stock 		A - Award 1,617 30,920 5.52 3,009.53 4,866,410 93,054,668
2021-02-03 2021-02-01 4 CATB CATABASIS PHARMACEUTICALS INC
Series X Convertible Preferred Stock 		A - Award 4,851 4,851 3,009.53 14,599,230 14,599,230
2021-02-01 2021-01-28 4 VYNE VYNE Therapeutics Inc.
Common Stock 		P - Purchase 4,219,409 27,095,819 18.44 2.37 9,999,999 64,217,091
2021-01-27 2021-01-25 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 311,111 3,425,916 9.99 22.50 6,999,998 77,083,110
2021-01-26 3 SCYX SCYNEXIS INC
Common Stock 		2,400,000
2021-01-26 2021-01-22 4 SCYX SCYNEXIS INC
Common Stock 		S - Sale -33,849 1,800,000 -1.85 8.95 -302,949 16,110,000
2021-01-26 2021-01-22 4 SCYX SCYNEXIS INC
Common Stock 		S - Sale -285,151 1,833,849 -13.46 8.16 -2,326,832 14,964,208
2021-01-26 2021-01-21 4 SCYX SCYNEXIS INC
Common Stock 		S - Sale -95,000 2,120,000 -4.29 7.38 -701,100 15,645,600
2021-01-26 2021-01-20 4 SCYX SCYNEXIS INC
Common Stock 		S - Sale -185,000 2,215,000 -7.71 7.43 -1,374,550 16,457,450
2021-01-22 2021-01-22 4 MOTS Motus GI Holdings, Inc.
Common Stock 		S - Sale -550,000 2,660,542 -17.13 1.48 -814,000 3,937,602
2021-01-22 2021-01-21 4 MOTS Motus GI Holdings, Inc.
Common Stock 		S - Sale -674,352 3,210,542 -17.36 1.68 -1,132,911 5,393,711
2021-01-22 2021-01-20 4 MOTS Motus GI Holdings, Inc.
Common Stock 		S - Sale -325,648 3,884,894 -7.73 1.80 -586,166 6,992,809
2021-01-21 2021-01-19 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 1,368,421 8,703,879 18.65 9.50 13,000,000 82,686,850
2021-01-11 2021-01-08 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 50,000 7,335,458 0.69 7.60 380,000 55,749,481
2021-01-11 2021-01-08 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 152,668 7,285,458 2.14 10.21 1,558,740 74,384,526
2021-01-11 2021-01-08 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 347,332 7,132,790 5.12 9.21 3,198,928 65,692,996
2021-01-11 2021-01-07 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 500,000 6,785,458 7.95 8.13 4,065,000 55,165,774
2020-12-15 2020-12-10 4 SLDB Solid Biosciences Inc.
Common Stock 		A - Award 4,054,054 10,803,857 60.06 3.70 15,000,000 39,974,271
2020-11-24 2020-11-23 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 500,000 6,933,277 7.77 12.85 6,425,000 89,092,609
2020-10-29 2020-10-27 4 CERE Cerevel Therapeutics Holdings, Inc.
Common stock 		P - Purchase 3,000,000 3,157,295 1,907.24 10.00 30,000,000 31,572,950
2020-10-22 2020-10-21 4 ARYB ARYA Sciences Acquisition Corp II
Class A ordinary shares 		P - Purchase 43,195 157,295 37.86 10.09 435,838 1,587,107
2020-10-22 2020-10-20 4 ARYB ARYA Sciences Acquisition Corp II
Class A ordinary shares 		P - Purchase 114,100 114,100 10.00 1,141,000 1,141,000
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Series B Preferred Stock 		C - Conversion -1,644,785 0 -100.00
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock 		P - Purchase 1,058,824 3,114,805 51.50 17.00 18,000,008 52,951,685
2020-09-22 2020-09-22 4 ATHA Athira Pharma, Inc.
Common Stock 		C - Conversion 1,644,785 2,055,981 400.00
2020-09-17 3 ATHA Athira Pharma, Inc.
Common Stock 		411,196
2020-09-16 2020-09-15 4 QTNT Quotient Ltd
Ordinary Shares 		P - Purchase 2,911,764 16,200,818 21.91 4.25 12,374,997 68,853,476
2020-09-15 2020-09-14 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		P - Purchase 400,000 2,360,139 20.41 40.00 16,000,000 94,405,560
2020-09-14 2020-09-14 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 1,800,000 13,532,467 15.34 11.00 19,800,000 148,857,137
2020-09-14 2020-09-10 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 200,000 11,732,467 1.73 11.24 2,248,000 131,872,929
2020-07-13 2020-07-09 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 3,200,000 6,285,458 103.71 4.25 13,600,000 26,713,196
2020-06-24 2020-06-22 4 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		P - Purchase 1,750,000 8,476,496 26.02 2.00 3,500,000 16,952,992
2020-06-18 2020-06-16 4 SLDB Solid Biosciences Inc.
Stock Option (Right to Buy) 		A - Award 30,000 30,000
2020-06-11 3 MNLO Menlo Therapeutics Inc.
Common Stock 		40,347,416
2020-06-11 3 MNLO Menlo Therapeutics Inc.
Common Stock 		40,347,416
2020-06-11 3 MNLO Menlo Therapeutics Inc.
Common Stock 		40,347,416
2020-06-11 3 MNLO Menlo Therapeutics Inc.
Common Stock 		40,347,416
2020-06-11 3 MNLO Menlo Therapeutics Inc.
Common Stock 		40,347,416
2020-06-11 2020-06-09 4 MNLO Menlo Therapeutics Inc.
Common Stock 		P - Purchase 2,702,702 22,876,410 13.40 1.85 4,999,999 42,321,358
2020-06-04 2020-06-02 4 MGTX MeiraGTx Holdings plc
Stock Option (right to buy) 		A - Award 25,000 25,000
2020-05-29 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		P - Purchase 625,000 1,934,115 47.74 16.00 10,000,000 30,945,840
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Warrants 		X - Other -339,604 0 -100.00
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Warrants 		X - Other -141,221 0 -100.00
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Series C Convertible Preferred Stock 		C - Conversion -16,232,511 0 -100.00
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Series C Convertible Preferred Stock 		C - Conversion -39,035,325 0 -100.00
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Series B Convertible Preferred Stock 		C - Conversion -26,666,666 0 -100.00
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		F - Taxes -183,174 1,288,446 -12.45 16.00 -2,930,784 20,615,136
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		X - Other 339,604 1,471,620 30.00 8.63 2,930,783 12,700,081
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		F - Taxes -76,172 1,309,115 -5.50 16.00 -1,218,752 20,945,840
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		X - Other 141,221 1,385,287 11.35 8.63 1,218,737 11,955,027
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		C - Conversion 470,739 1,244,066 60.87
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		C - Conversion 1,132,016 1,132,016
2020-05-06 2020-05-05 4 LYRA Lyra Therapeutics, Inc.
Common Stock 		C - Conversion 773,327 773,327
2020-05-01 2020-04-30 4 LYRA Lyra Therapeutics, Inc.
Stock Option 		A - Award 14,500 14,500
2020-05-01 2020-04-30 4 LYRA Lyra Therapeutics, Inc.
Stock Option 		A - Award 14,500 14,500
2020-04-28 2020-04-24 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 9,090,909 55,042,456 19.78 1.10 10,000,000 60,546,702
2020-04-20 3 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		13,452,992
2020-04-20 3 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		13,452,992
2020-04-20 3 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		13,452,992
2020-04-20 3 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		13,452,992
2020-04-20 3 LPTX LEAP THERAPEUTICS, INC.
Common Stock 		13,452,992
2020-04-20 2020-04-17 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 1,071,428 3,659,381 41.40 14.00 14,999,992 51,231,334
2020-03-23 2020-03-19 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		P - Purchase 500,000 16,584,802 3.11 2.10 1,050,000 34,828,084
2020-03-17 2020-03-13 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 1,000,000 15,919,925 6.70 1.75 1,750,000 27,859,869
2020-02-25 2020-02-25 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 3,000,000 14,919,925 25.17 3.00 9,000,000 44,759,775
2020-02-25 2020-02-10 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy) 		J - Other 700,000 700,000
2020-02-25 2020-02-10 4 AGRX AGILE THERAPEUTICS INC
Warrants (right to buy) 		J - Other 700,000 700,000
2020-02-11 2020-02-11 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		P - Purchase 4,563,700 16,084,802 39.61 3.50 15,972,950 56,296,807
2020-02-04 2020-02-03 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		P - Purchase 255,809 1,960,139 15.01 21.00 5,371,989 41,162,919
2019-12-27 2019-12-24 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 73,698 11,532,467 0.64 14.39 1,060,514 165,952,200
2019-12-26 2019-12-23 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 153,237 11,458,769 1.36 14.30 2,191,289 163,860,397
2019-12-26 2019-12-20 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 189,322 11,305,532 1.70 14.14 2,677,013 159,860,222
2019-12-26 2019-12-19 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 120,931 11,116,210 1.10 13.86 1,676,104 154,070,671
2019-12-26 2019-12-19 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 142,812 10,995,279 1.32 13.72 1,959,381 150,855,228
2019-11-18 2019-11-18 4 KDMN Kadmon Holdings, Inc.
Common Stock 		P - Purchase 1,470,588 14,636,334 11.17 3.40 4,999,999 49,763,536
2019-11-18 2019-11-15 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 333,800 11,919,925 2.88 1.74 580,812 20,740,670
2019-11-18 2019-11-15 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 2,000,000 11,586,125 20.86 1.60 3,200,000 18,537,800
2019-11-18 2019-11-15 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 3,000,000 9,586,125 45.55 1.72 5,160,000 16,488,135
2019-11-18 2019-11-14 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 435,015 6,586,125 7.07 1.69 735,175 11,130,551
2019-11-15 2019-11-12 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		J - Other -3,125,851 0 -100.00
2019-11-12 2019-11-07 4 QTNT Quotient Ltd
Ordinary Shares 		P - Purchase 2,500,000 13,289,054 23.17 7.00 17,500,000 93,023,378
2019-10-31 2019-10-29 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		S - Sale -760,291 6,151,110 -11.00 0.44 -334,528 2,706,488
2019-10-30 2019-10-28 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		S - Sale -3,815,349 6,911,401 -35.57 0.51 -1,945,828 3,524,815
2019-10-30 2019-08-06 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		P - Purchase 2,300,000 10,726,750 27.29 0.95 2,185,000 10,190,412
2019-10-21 2019-10-17 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 50,000 10,852,467 0.46 10.93 546,500 118,617,464
2019-10-18 2019-10-16 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 67,222 10,802,467 0.63 10.29 691,714 111,157,385
2019-09-24 2019-09-23 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 20,000,000 45,951,556 77.07 0.50 10,000,000 22,975,778
2019-09-18 2019-09-16 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 30,000 10,735,245 0.28 13.58 407,400 145,784,627
2019-09-16 2019-09-13 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 56,416 10,705,245 0.53 14.27 805,056 152,763,846
2019-09-16 2019-09-12 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 13,584 10,648,829 0.13 14.05 190,855 149,616,047
2019-08-20 2019-08-12 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 425,531 6,433,277 7.08 23.50 9,999,978 151,182,010
2019-08-16 2019-08-16 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 20,000 10,635,245 0.19 14.96 299,200 159,103,265
2019-08-16 2019-08-15 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 30,000 10,615,245 0.28 15.00 450,000 159,228,675
2019-08-09 2019-08-08 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 30,000 10,585,245 0.28 15.76 472,800 166,823,461
2019-08-09 2019-08-07 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 37,764 10,555,245 0.36 15.79 596,294 166,667,319
2019-08-09 2019-08-07 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 248,752 10,517,481 2.42 15.04 3,741,230 158,182,914
2019-08-09 2019-08-07 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 371,756 10,268,729 3.76 14.14 5,256,630 145,199,828
2019-08-09 2019-08-07 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 74,855 9,896,973 0.76 13.12 982,098 129,848,286
2019-08-09 2019-06-25 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 1,495 9,822,118 0.02 17.89 26,746 175,717,691
2019-08-09 2019-06-24 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 20,786 9,820,623 0.21 17.90 372,069 175,789,152
2019-08-09 2019-06-21 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 23,073 9,799,837 0.24 17.85 411,853 174,927,090
2019-08-06 3 FOMX Foamix Pharmaceuticals Ltd.
Common Stock 		22,407,762
2019-08-06 3 FOMX Foamix Pharmaceuticals Ltd.
Common Stock 		22,407,762
2019-08-06 3 FOMX Foamix Pharmaceuticals Ltd.
Common Stock 		22,407,762
2019-08-06 3 FOMX Foamix Pharmaceuticals Ltd.
Common Stock 		22,407,762
2019-08-06 3 FOMX Foamix Pharmaceuticals Ltd.
Common Stock 		22,407,762
2019-07-29 2019-07-25 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 2,822,581 6,749,803 71.87 4.65 13,125,002 31,386,584
2019-07-11 2019-07-11 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 42,916 3,708,705 1.17 16.67 715,410 61,824,112
2019-07-11 2019-07-10 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 12,354 3,665,789 0.34 16.89 208,659 61,915,176
2019-07-11 2019-07-09 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 29,834 3,653,435 0.82 16.61 495,543 60,683,555
2019-07-09 2019-07-05 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 50,000 3,632,601 1.40 16.46 823,000 59,792,612
2019-07-03 2019-07-03 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 1,705 3,573,601 0.05 16.67 28,422 59,571,929
2019-07-03 2019-07-02 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 715 3,571,896 0.02 16.14 11,540 57,650,401
2019-07-03 2019-07-01 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 18,121 3,571,181 0.51 14.24 258,043 50,853,617
2019-07-01 2019-06-28 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 39,383 3,553,060 1.12 14.48 570,266 51,448,309
2019-07-01 2019-06-28 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 60,617 3,513,560 1.76 13.97 846,819 49,084,433
2019-07-01 2019-06-27 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 186,696 3,453,060 5.72 13.58 2,535,332 46,892,555
2019-07-01 2019-06-27 4 DOVA Dova Pharmaceuticals Inc.
Common Stock 		P - Purchase 140,513 3,266,364 4.50 12.46 1,750,792 40,698,895
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 1,000,000 4,210,542 31.15 3.00 3,000,000 12,631,626
2019-06-21 2019-06-19 4 MGTX MeiraGTx Holdings plc
Stock Option (right to buy) 		A - Award 25,000 25,000
2019-06-20 2019-06-18 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 1,000,000 25,951,556 4.01 0.65 650,000 16,868,511
2019-06-20 2019-06-18 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 50,742 9,776,764 0.52 17.73 899,656 173,342,026
2019-06-19 2019-06-17 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 130,000 9,726,022 1.35 17.94 2,332,200 174,484,835
2019-06-18 2019-06-17 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 1,000,000 24,951,556 4.18 0.62 618,000 15,420,062
2019-06-18 2019-06-14 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 324,290 9,596,022 3.50 17.69 5,736,690 169,753,629
2019-06-17 2019-06-13 4 SLDB Solid Biosciences Inc.
Stock Option (Right to Buy) 		A - Award 10,000 10,000
2019-06-17 2019-06-13 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 75,710 9,271,732 0.82 17.05 1,290,856 158,083,031
2019-05-23 2019-05-21 4 ADMA ADMA BIOLOGICS, INC.
Common Stock 		P - Purchase 4,000,000 11,521,102 53.18 4.00 16,000,000 46,084,408
2019-05-23 2019-05-03 4 ADMA ADMA BIOLOGICS, INC.
Warrants (right to buy) 		P - Purchase 250,000 250,000
2019-05-23 2019-02-11 4 ADMA ADMA BIOLOGICS, INC.
Warrants (right to buy) 		P - Purchase 1,360,000 1,360,000
2019-05-08 3 ATNX Athenex, Inc.
Common Stock 		18,192,044
2019-05-08 3 ATNX Athenex, Inc.
Common Stock 		18,192,044
2019-05-08 3 ATNX Athenex, Inc.
Common Stock 		18,192,044
2019-05-08 3 ATNX Athenex, Inc.
Common Stock 		18,192,044
2019-05-08 3 ATNX Athenex, Inc.
Common Stock 		18,192,044
2019-05-08 2019-05-06 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 77,010 9,196,022 0.84 12.90 993,429 118,628,684
2019-05-08 2019-05-06 4 ATNX Athenex, Inc.
Common Stock 		P - Purchase 22,990 9,119,012 0.25 12.08 277,719 110,157,665
2019-03-06 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		16,853,500
2019-03-06 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		16,853,500
2019-03-06 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		16,853,500
2019-03-06 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		16,853,500
2019-03-06 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		16,853,500
2019-03-05 2019-03-01 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 1,304,348 6,007,746 27.73 13.80 18,000,002 82,906,895
2019-01-17 2018-12-24 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 400,000 3,210,541 14.23 2.70 1,080,000 8,668,461
2019-01-17 2018-02-14 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 10,000 2,810,541 0.36 5.00 50,000 14,052,705
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -450,235 2,253,376 -16.65 5.26 -2,368,236 11,852,758
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -800,000 2,703,611 -22.83 5.25 -4,200,000 14,193,958
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -25,800 3,503,611 -0.73 6.46 -166,668 22,633,327
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -25,800 3,503,611 -0.73 6.46 -166,668 22,633,327
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -4,200 3,529,411 -0.12 5.26 -22,092 18,564,702
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -4,200 3,529,411 -0.12 5.26 -22,092 18,564,702
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -4,592 3,563,611 -0.13 9.52 -43,716 33,925,577
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -34,401 3,568,203 -0.95 9.05 -311,329 32,292,237
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -131,866 3,602,604 -3.53 7.56 -996,907 27,235,686
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -147,497 3,734,470 -3.80 6.67 -983,805 24,908,915
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		S - Sale -431,644 3,881,967 -10.01 5.64 -2,434,472 21,894,294
2018-12-17 2018-12-13 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 14,285,714 23,631,439 152.86 1.40 20,000,000 33,084,015
2018-12-10 2018-12-07 4 QTNT Quotient Ltd
Ordinary Shares 		P - Purchase 2,000,000 10,789,054 22.76 6.50 13,000,000 70,128,851
2018-10-15 2018-10-12 4 CORI Corium International, Inc.
Common Stock 		S - Sale -2,350,000 2,724,686 -46.31 12.52 -29,422,000 34,113,069
2018-10-15 2018-10-12 4 CORI Corium International, Inc.
Common Stock 		S - Sale -500,000 5,074,686 -8.97 12.51 -6,255,000 63,484,322
2018-10-15 2018-10-11 4 CORI Corium International, Inc.
Common Stock 		S - Sale -500,000 5,574,686 -8.23 12.50 -6,250,000 69,683,575
2018-10-15 2018-10-11 4 CORI Corium International, Inc.
Common Stock 		S - Sale -282,447 6,074,686 -4.44 12.51 -3,533,412 75,994,322
2018-10-05 2018-10-03 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 30,000 20,724,424 0.14 12.69 380,700 262,992,941
2018-10-05 2018-09-24 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 20,000 20,694,424 0.10 12.45 249,000 257,645,579
2018-09-25 2018-09-21 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 50,000 20,674,424 0.24 12.53 626,500 259,050,533
2018-09-17 2018-09-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 100,000 20,624,424 0.49 11.74 1,174,000 242,130,738
2018-09-14 2018-09-12 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 500,000 20,524,424 2.50 12.00 6,001,500 246,354,661
2018-08-27 2018-07-20 4/A CRNX Crinetics Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -6,186,205 0 -100.00
2018-08-27 2018-07-20 4/A CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 400,000 2,587,953 18.28 17.00 6,800,000 43,995,201
2018-08-27 2018-07-20 4/A CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		C - Conversion 1,880,305 2,187,953 611.19
2018-08-27 2018-07-18 4/A CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 307,648 307,648 21.30 6,552,902 6,552,902
2018-08-14 2018-08-10 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 100,000 4,070,357 2.52 52.00 5,200,000 211,658,564
2018-08-01 2018-06-19 4 VRCA Verrica Pharmaceuticals Inc.
Series C Preferred Stock 		C - Conversion -2,193,463 0 -100.00
2018-08-01 2018-06-19 4 VRCA Verrica Pharmaceuticals Inc.
Series B Preferred Stock 		C - Conversion -1,937,984 0 -100.00
2018-08-01 2018-06-19 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		P - Purchase 1,000,000 3,410,412 41.49 15.00 15,000,000 51,156,180
2018-08-01 2018-06-19 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		C - Conversion 1,279,733 2,410,412 113.18
2018-08-01 2018-06-19 4 VRCA Verrica Pharmaceuticals Inc.
Common Stock 		C - Conversion 1,130,679 1,130,679
2018-07-27 2018-07-25 4 SLDB Solid Biosciences Inc.
Stock Option (Right to Buy) 		A - Award 1,835 1,835
2018-07-26 2018-07-26 4 AGRX AGILE THERAPEUTICS INC
Common Stock 		S - Sale -298,628 3,231,372 -8.46 0.30 -89,439 967,796
2018-07-20 2018-07-18 4 QTNT Quotient Ltd
Warrants (right to buy) 		X - Other -2,306,034 0 -100.00
2018-07-20 2018-07-18 4 QTNT Quotient Ltd
Ordinary Shares 		X - Other 2,306,034 8,789,054 35.57 5.80 13,374,997 50,976,513
2018-07-20 2018-07-20 4 CRNX Crinetics Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -6,186,205 0 -100.00
2018-07-20 2018-07-20 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		P - Purchase 400,000 2,280,305 21.27 17.00 6,800,000 38,765,185
2018-07-20 2018-07-20 4 CRNX Crinetics Pharmaceuticals, Inc.
Common Stock 		C - Conversion 1,880,305 1,880,305
2018-06-22 3 KDMN Kadmon Holdings, Inc.
Common Stock 		26,331,492
2018-06-22 3 KDMN Kadmon Holdings, Inc.
Common Stock 		26,331,492
2018-06-22 3 KDMN Kadmon Holdings, Inc.
Common Stock 		26,331,492
2018-06-22 3 KDMN Kadmon Holdings, Inc.
Common Stock 		26,331,492
2018-06-22 3 KDMN Kadmon Holdings, Inc.
Common Stock 		26,331,492
2018-06-13 2018-06-11 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 5,591 3,125,851 0.18 29.82 166,724 93,212,877
2018-06-13 2018-06-11 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 14,109 3,120,260 0.45 29.18 411,701 91,049,187
2018-06-12 2018-06-08 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 2,000 3,106,151 0.06 28.97 57,940 89,985,194
2018-06-12 2018-06-08 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 23,000 3,104,151 0.75 28.62 658,260 88,840,802
2018-06-12 2018-06-12 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 1,333,333 4,703,398 39.56 15.00 19,999,995 70,550,970
2018-06-12 2018-06-08 4 MGTX MeiraGTx Holdings plc
Ordinary Shares 		P - Purchase 50,000 3,370,065 1.51 15.22 761,000 51,292,389
2018-06-11 2018-06-07 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 8,400 3,081,151 0.27 29.16 244,944 89,846,363
2018-06-11 2018-06-07 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 19,223 3,072,751 0.63 28.40 545,933 87,266,128
2018-06-11 2018-06-07 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 22,377 3,053,528 0.74 27.63 618,277 84,368,979
2018-06-08 2018-06-06 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 51,763 3,031,151 1.74 28.99 1,500,609 87,873,067
2018-06-08 2018-06-06 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 48,237 2,979,388 1.65 28.30 1,365,107 84,316,680
2018-06-08 3 MGTX MeiraGTx Holdings plc
Ordinary shares 		6,640,130
2018-06-08 3 MGTX MeiraGTx Holdings plc
Ordinary shares 		6,640,130
2018-06-08 3 MGTX MeiraGTx Holdings plc
Ordinary shares 		6,640,130
2018-06-08 3 MGTX MeiraGTx Holdings plc
Ordinary shares 		6,640,130
2018-06-08 3 MGTX MeiraGTx Holdings plc
Ordinary shares 		6,640,130
2018-06-07 2018-06-05 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 3,168 2,931,151 0.11 27.13 85,948 79,522,127
2018-06-07 2018-06-05 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 56,162 2,927,983 1.96 26.31 1,477,622 77,035,233
2018-06-07 2018-06-05 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 40,670 2,871,821 1.44 25.45 1,035,052 73,087,844
2018-06-06 2018-06-04 4 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		P - Purchase 10,000 2,831,151 0.35 25.07 250,700 70,976,956
2018-06-06 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		5,642,302
2018-06-06 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		5,642,302
2018-06-06 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		5,642,302
2018-06-06 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		5,642,302
2018-06-06 3 DOVA Dova Pharmaceuticals, Inc.
Common Stock 		5,642,302
2018-05-24 2018-05-23 4 QTNT Quotient Ltd
Ordinary Shares 		P - Purchase 231,992 6,483,020 3.71 6.65 1,542,747 43,112,083
2018-05-24 2018-05-22 4 QTNT Quotient Ltd
Ordinary Shares 		P - Purchase 218,008 6,251,028 3.61 6.24 1,360,370 39,006,415
2018-03-28 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		7,060,000
2018-03-28 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		7,060,000
2018-03-28 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		7,060,000
2018-03-28 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		7,060,000
2018-03-28 3 AGRX AGILE THERAPEUTICS INC
Common Stock 		7,060,000
2018-03-26 2018-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		P - Purchase 700,000 4,313,611 19.37 29.50 20,650,000 127,251,524
2018-03-07 2018-03-05 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 335,827 18,424,424 1.86 13.56 4,553,814 249,835,189
2018-03-06 2018-03-02 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 100,000 18,088,597 0.56 13.90 1,389,500 251,341,055
2018-03-05 2018-03-01 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 100,000 17,988,597 0.56 13.69 1,369,000 246,263,893
2018-02-21 2018-02-16 4 MOTS Motus GI Holdings, Inc.
Series A Convertible Preferred Stock 		C - Conversion -256,386 0 -100.00
2018-02-21 2018-02-16 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 1,000,000 2,800,541 55.54 5.00 5,000,000 14,002,705
2018-02-21 2018-02-16 4 MOTS Motus GI Holdings, Inc.
Common Stock 		C - Conversion 256,386 1,800,541 16.60
2018-02-21 2018-02-16 4 MOTS Motus GI Holdings, Inc.
Warrant (right to buy) 		J - Other 180,055 180,055
2018-02-20 2018-02-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		P - Purchase 50,000 3,613,611 1.40 32.42 1,621,000 117,153,269
2018-02-15 2018-02-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		P - Purchase 100,000 3,563,611 2.89 32.69 3,269,000 116,494,444
2018-02-15 2018-02-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		P - Purchase 75,000 3,463,611 2.21 32.75 2,456,250 113,433,260
2018-02-13 3 MOTS Motus GI Holdings, Inc.
Common Stock 		3,088,310
2018-02-13 3 MOTS Motus GI Holdings, Inc.
Common Stock 		3,088,310
2018-02-13 3 MOTS Motus GI Holdings, Inc.
Common Stock 		3,088,310
2018-02-13 3 MOTS Motus GI Holdings, Inc.
Common Stock 		3,088,310
2018-01-30 2018-01-30 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 20,000 3,927,222 0.51 27.33 546,520 107,315,268
2018-01-30 2018-01-30 4 SLDB Solid Biosciences Inc.
Common Stock 		P - Purchase 1,000,000 3,907,222 34.40 16.00 16,000,000 62,515,552
2018-01-25 2018-01-25 4 ALBO ALBIREO PHARMA, INC.
Common Stock 		P - Purchase 275,000 1,595,000 20.83 33.00 9,075,000 52,635,000
2018-01-25 3 SLDB Solid Biosciences, LLC
Common Stock 		5,814,444
2018-01-25 3 SLDB Solid Biosciences, LLC
Common Stock 		5,814,444
2018-01-25 3 SLDB Solid Biosciences, LLC
Common Stock 		5,814,444
2018-01-25 3 SLDB Solid Biosciences, LLC
Common Stock 		5,814,444
2018-01-18 2018-01-18 4 CORI Corium International, Inc.
Common Stock 		P - Purchase 310,000 6,357,133 5.13 12.80 3,968,000 81,371,302
2018-01-18 2018-01-17 4 CORI Corium International, Inc.
Common Stock 		P - Purchase 149,650 6,047,133 2.54 12.24 1,831,716 74,016,908
2018-01-18 2018-01-16 4 CORI Corium International, Inc.
Common Stock 		P - Purchase 50,350 5,897,483 0.86 11.83 595,640 69,767,224
2017-12-19 2017-12-19 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		P - Purchase 175,000 4,889,066 3.71 38.00 6,650,000 185,784,508
2017-12-18 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		6,777,222
2017-12-18 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		6,777,222
2017-12-18 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		6,777,222
2017-12-18 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock 		6,777,222
2017-12-15 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		9,428,132
2017-12-15 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		9,428,132
2017-12-15 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		9,428,132
2017-12-15 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		9,428,132
2017-12-04 3 ALBO ALBIREO PHARMA, INC.
Common stock 		2,640,000
2017-12-04 3 ALBO ALBIREO PHARMA, INC.
Common stock 		2,640,000
2017-12-04 3 ALBO ALBIREO PHARMA, INC.
Common stock 		2,640,000
2017-12-04 3 ALBO ALBIREO PHARMA, INC.
Common stock 		2,640,000
2017-11-15 3 ADMA ADMA BIOLOGICS, INC.
Common stock, par value $0.0001 per share 		7,642,204
2017-11-15 3 ADMA ADMA BIOLOGICS, INC.
Common stock, par value $0.0001 per share 		7,642,204
2017-11-15 3 ADMA ADMA BIOLOGICS, INC.
Common stock, par value $0.0001 per share 		7,642,204
2017-11-15 3 ADMA ADMA BIOLOGICS, INC.
Common stock, par value $0.0001 per share 		7,642,204
2017-11-01 3/A QTNT Quotient Ltd
Ordinary Shares 		6,033,020
2017-10-30 2017-10-26 4 VBIV VBI Vaccines Inc/BC
Common Stock 		P - Purchase 3,100,000 9,345,725 49.63 3.05 9,455,000 28,504,461
2017-10-26 3 QTNT Quotient Ltd
Ordinary Shares 		12,086,040
2017-10-26 3 QTNT Quotient Ltd
Ordinary Shares 		12,086,040
2017-10-26 3 QTNT Quotient Ltd
Ordinary Shares 		12,086,040
2017-10-26 3 QTNT Quotient Ltd
Ordinary Shares 		12,086,040
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 22,055 3,670,357 0.60 27.67 610,341 101,571,991
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 8,920 3,648,302 0.25 40.14 358,081 146,455,976
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 12,586 3,639,382 0.35 39.22 493,600 142,730,011
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 8,112 3,626,796 0.22 38.56 312,791 139,845,990
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 6,153 3,618,684 0.17 37.14 228,530 134,402,266
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 3,800 3,612,531 0.11 36.26 137,805 131,006,630
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 6,000 3,608,731 0.17 34.91 209,475 125,989,821
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 8,260 3,602,731 0.23 33.86 279,665 121,980,185
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 15,937 3,594,471 0.45 32.96 525,311 118,479,875
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 102,199 3,578,534 2.94 31.90 3,260,240 114,158,455
2017-10-03 2017-09-29 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 28,033 3,476,335 0.81 31.19 874,220 108,410,898
2017-10-03 2017-10-03 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 300,000 3,970,357 8.17 37.50 11,250,000 148,888,388
2017-09-25 2017-09-22 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -350,000 2,099,563 -14.29 3.35 -1,172,500 7,033,536
2017-09-25 2017-09-22 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -500,000 2,449,563 -16.95 3.27 -1,633,250 8,001,498
2017-09-25 2017-09-22 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -250,000 2,949,563 -7.81 3.17 -792,500 9,350,115
2017-09-25 2017-09-22 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -250,000 3,199,563 -7.25 3.03 -757,250 9,691,476
2017-09-25 2017-09-22 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -300,000 3,449,563 -8.00 3.09 -926,250 10,650,526
2017-09-25 2017-09-21 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -353,421 3,749,563 -8.61 3.56 -1,258,143 13,348,069
2017-09-25 2017-09-21 4 VSAR Versartis, Inc.
Common Stock 		S - Sale -126,579 4,102,984 -2.99 3.74 -473,659 15,353,366
2017-09-21 2017-09-19 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 200,000 3,085,458 6.93 7.25 1,450,000 22,369,570
2017-07-14 2017-07-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 1,500,000 17,888,597 9.15 12.25 18,375,000 219,135,313
2017-07-05 2017-06-30 4 CORI Corium International, Inc.
Common Stock 		P - Purchase 301,004 5,847,133 5.43 7.70 2,319,236 45,052,160
2017-07-05 2017-06-30 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 296,007 2,885,458 11.43 4.60 1,361,632 13,273,107
2017-07-05 2017-06-30 4 ZGNX ZOGENIX, INC.
Common Stock 		P - Purchase 175,653 3,448,302 5.37 14.45 2,538,186 49,827,964
2017-06-21 2017-06-19 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -875,000 4,533,728 -16.18 2.40 -2,100,000 10,880,947
2017-05-25 2017-05-25 4 CORI Corium International, Inc.
Common Stock 		P - Purchase 1,902,400 5,546,129 52.21 6.25 11,890,000 34,663,306
2017-05-25 3 CORI Corium International, Inc.
Common Stock 		7,287,458
2017-05-25 3 CORI Corium International, Inc.
Common Stock 		7,287,458
2017-05-25 3 CORI Corium International, Inc.
Common Stock 		7,287,458
2017-05-25 3 CORI Corium International, Inc.
Common Stock 		7,287,458
2017-05-18 3 ZGNX ZOGENIX, INC.
Common Stock 		6,545,298
2017-05-18 3 ZGNX ZOGENIX, INC.
Common Stock 		6,545,298
2017-05-18 3 ZGNX ZOGENIX, INC.
Common Stock 		6,545,298
2017-05-18 3 ZGNX ZOGENIX, INC.
Common Stock 		6,545,298
2017-03-20 3 KDMN Kadmon Holdings, Inc.
Common Stock 		9,910,948
2017-03-20 3 KDMN Kadmon Holdings, Inc.
Common Stock 		9,910,948
2017-03-14 2017-02-13 4/A VSAR Versartis, Inc.
Common Stock 		P - Purchase 59,133 4,229,563 1.42 15.51 917,425 65,619,978
2017-03-14 2017-02-10 4/A VSAR Versartis, Inc.
Common Stock 		P - Purchase 34,883 4,170,430 0.84 14.94 521,281 62,321,655
2017-02-15 2017-02-14 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 893,025 2,589,451 52.64 4.50 4,018,612 11,652,530
2017-02-14 2017-02-13 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 59,133 4,228,563 1.42 15.51 917,425 65,604,464
2017-02-14 2017-02-10 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 34,883 4,169,430 0.84 14.94 521,281 62,306,711
2017-02-10 2017-02-09 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 41,211 4,134,547 1.01 14.27 587,928 58,984,688
2017-02-10 2017-02-08 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 104,612 4,093,336 2.62 13.51 1,413,319 55,301,379
2017-01-04 2016-12-30 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 94,750 4,013,411 2.42 14.66 1,388,846 58,828,578
2017-01-04 2016-12-30 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 94,750 16,293,847 0.58 4.96 470,055 80,833,775
2017-01-04 2016-12-30 4/A VSAR Versartis, Inc.
Common Stock 		P - Purchase 71,063 3,989,724 1.81 14.66 1,041,641 58,481,374
2016-12-30 2016-12-29 4 VSAR Versartis, Inc.
Common Stock 		P - Purchase 47,375 3,918,661 1.22 14.37 680,589 56,295,484
2016-12-30 2016-12-29 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 94,750 16,293,847 0.58 4.85 459,916 79,090,333
2016-12-30 2016-12-28 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 47,375 16,199,097 0.29 4.91 232,706 79,569,964
2016-12-27 2016-12-23 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 37,900 16,151,722 0.24 4.92 186,582 79,514,927
2016-12-27 2016-12-23 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 47,375 16,113,822 0.29 4.72 223,468 76,008,898
2016-12-23 2016-12-22 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 189,500 16,066,447 1.19 4.51 854,834 72,475,742
2016-12-08 2016-12-06 4 VBIV VBI VACCINES INC.
Warrant 		P - Purchase 1,341,282 2,068,824 184.36 3.36 4,500,001 6,940,905
2016-12-08 2016-12-06 4 VBIV VBI VACCINES INC.
Warrant 		P - Purchase 363,771 727,542 100.00 4.13 1,502,374 3,004,748
2016-12-08 2016-12-06 4 VBIV VBI VACCINES INC.
Common Stock 		P - Purchase 3,383,955 6,213,314 119.60 3.05 10,321,063 18,950,608
2016-12-02 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		26,447,894
2016-12-02 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		26,447,894
2016-12-02 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		26,447,894
2016-12-02 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		26,447,894
2016-12-02 3/A FOLD AMICUS THERAPEUTICS INC
Common Stock 		15,876,947
2016-10-05 3/A VSAR Versartis, Inc.
Common Stock 		3,871,286
2016-09-30 2016-09-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -97,200 5,386,410 -1.77 3.88 -377,117 20,898,194
2016-09-30 2016-09-28 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -119,300 5,483,610 -2.13 3.96 -472,380 21,712,902
2016-09-28 3 VSAR Versartis, Inc.
Common Stock 		7,594,838
2016-09-28 3 VSAR Versartis, Inc.
Common Stock 		7,594,838
2016-09-28 3 VSAR Versartis, Inc.
Common Stock 		7,594,838
2016-09-28 3 VSAR Versartis, Inc.
Common Stock 		7,594,838
2016-09-16 2016-09-15 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -115,923 5,602,910 -2.03 3.63 -420,511 20,324,556
2016-09-16 2016-09-15 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -276,927 5,718,833 -4.62 3.73 -1,032,301 21,318,094
2016-08-26 2016-08-25 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		S - Sale -1,100,000 14,139,444 -7.22 6.81 -7,491,000 96,289,614
2016-05-26 2016-05-26 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 700,000 1,940,458 56.43 5.00 3,500,000 9,702,290
2015-11-19 2015-11-18 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -42,300 5,995,760 -0.70 5.35 -226,132 32,052,733
2015-11-19 2015-11-17 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -133,900 6,038,060 -2.17 5.36 -717,409 32,350,718
2015-11-09 2015-11-06 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -17,100 6,171,960 -0.28 4.47 -76,365 27,562,739
2015-11-09 2015-11-05 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -75,000 6,189,060 -1.20 4.62 -346,260 28,573,652
2015-11-05 2015-10-28 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 45,100 1,240,458 3.77 6.50 293,150 8,062,977
2015-10-28 2015-10-26 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 50,000 1,195,358 4.37 6.46 323,150 7,725,599
2015-10-26 2015-10-22 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 18,020 1,145,358 1.60 6.47 116,661 7,415,048
2015-10-22 2015-10-20 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 22,797 1,127,338 2.06 6.44 146,858 7,262,311
2015-10-22 2015-10-20 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		P - Purchase 14,348 1,104,541 1.32 6.30 90,335 6,954,190
2015-10-22 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		2,180,386
2015-10-22 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		2,180,386
2015-10-22 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		2,180,386
2015-10-22 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock 		2,180,386
2015-10-08 2015-10-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 50,000 15,239,444 0.33 6.27 313,500 95,551,314
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 7,000 15,189,444 0.05 6.34 44,380 96,301,075
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 14,000 15,182,444 0.09 6.47 90,580 98,230,413
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 14,000 15,168,444 0.09 6.65 93,100 100,870,153
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 43,000 15,154,444 0.28 6.34 272,620 96,079,175
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 86,000 15,111 -121.32 6.47 556,420 97,771
2015-10-07 2015-10-06 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 86,000 15,025,444 0.58 6.65 571,900 99,919,203
2015-10-07 2015-10-05 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 35,000 14,939,444 0.23 6.76 236,600 100,990,641
2015-10-07 2015-10-05 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 35,000 14,904,444 0.24 6.85 239,750 102,095,441
2015-10-07 2015-10-05 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 215,000 14,869,444 1.47 6.76 1,453,400 100,517,441
2015-10-07 2015-10-05 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 215,000 14,654,444 1.49 6.85 1,472,750 100,382,941
2015-09-11 2015-09-09 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		S - Sale -310,000 6,264,060 -4.72 4.18 -1,294,777 26,163,099
2015-08-18 2015-08-14 4 VBIV VBI VACCINES INC.
Common Stock 		P - Purchase 650,000 3,260,356 24.90 2.08 1,352,000 6,781,540
2014-11-19 2014-11-19 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 2,100,000 14,439,444 17.02 6.50 13,650,000 93,856,386
2014-07-01 2014-06-30 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 530,000 12,339,444 4.49 3.50 1,855,000 43,188,054
2014-07-01 2014-06-30 4 FOLD AMICUS THERAPEUTICS INC
Common Stock 		P - Purchase 3,470,000 11,809,444 41.61 3.50 12,145,000 41,333,054
2014-05-30 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		16,678,888
2014-05-30 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		16,678,888
2014-05-30 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		16,678,888
2014-05-30 3 FOLD AMICUS THERAPEUTICS INC
Common Stock 		16,678,888
2013-11-12 2013-11-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,500 6,574,060 0.10 6.50 42,238 42,718,899
2013-11-12 2013-11-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 93,500 6,567,560 1.44 6.50 607,572 42,676,662
2013-11-12 2013-11-06 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,500 6,474,060 0.10 6.52 42,358 42,188,859
2013-11-12 2013-11-06 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 93,500 6,467,560 1.47 6.52 609,302 42,146,501
2013-11-06 2013-11-04 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 3,250 6,374,060 0.05 6.84 22,220 43,579,448
2013-11-06 2013-11-04 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 46,750 6,370,810 0.74 6.84 319,630 43,557,228
2013-11-06 2013-11-04 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,825 6,324,060 0.11 6.88 46,959 43,512,062
2013-11-06 2013-11-04 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 98,175 6,317,235 1.58 6.88 675,483 43,465,104
2013-11-04 2013-11-01 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 150,218 6,219,060 2.48 7.17 1,077,033 44,589,416
2013-11-04 2013-11-01 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 10,442 6,068,842 0.17 7.17 74,867 43,512,383
2013-11-04 2013-10-31 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 8,000 6,058,400 0.13 6.69 53,546 40,550,083
2013-11-04 2013-10-31 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 192,000 6,050,400 3.28 6.69 1,285,094 40,496,537
2013-09-09 2013-09-05 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale -50,000 2,823,426 -1.74 89.20 -4,460,000 251,849,599
2013-09-09 2013-09-05 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale -700,000 2,873,426 -19.59 89.20 -62,440,000 256,309,599
2013-09-09 2013-06-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Call option (right to buy) 		X - Other -1,000 0 -100.00
2013-09-09 2013-06-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Call option (right to buy) 		X - Other -1,000 0 -100.00
2013-09-09 2013-06-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		X - Other 100,000 3,573,426 2.88 25.00 2,500,000 89,335,650
2013-09-09 2013-06-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		X - Other 100,000 3,473,426 2.96 25.00 2,500,000 86,835,650
2013-07-24 2013-07-23 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		P - Purchase 850,000 5,858,400 16.97 11.65 9,902,500 68,250,360
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 500 22,000 2.33
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 500 22,000 2.33
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 500 22,500 2.27
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 500 23,000 2.22
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 500 23,500 2.17
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 1,000 24,000 4.35
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 1,000 24,000 4.35
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 1,000 25,000 4.17
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 1,500 26,000 6.12
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 2,000 27,500 7.84
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 2,000 27,500 7.84
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 6,000 29,500 25.53
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 1,000 36,000 2.86
2013-03-20 2013-03-16 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to sell) 		E - Other 4,000 40,000 11.11
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 500 44,000 1.15
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 500 44,000 1.15
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 500 44,500 1.14
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 500 45,000 1.12
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,000 45,500 2.25
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,000 45,500 2.25
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 500
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,000 47,500 2.15
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,000 48,500 2.11
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,500 49,500 3.12
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,500 49,500 3.12
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 4,000 51,000 8.51
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 4,000 51,000 8.51
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 1,000 55,000 1.85
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		X - Other 2,000 56,000 3.70
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -50,000 812,560 -5.80 10.00 -500,000 8,125,600
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -50,000 812,560 -5.80 10.00 -500,000 8,125,600
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -50,000 862,560 -5.48 12.50 -625,000 10,782,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -50,000 862,560 -5.48 12.50 -625,000 10,782,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -50,000 862,560 -5.48 12.50 -625,000 10,782,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -100,000 962,560 -9.41 12.50 -1,250,000 12,032,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -100,000 962,560 -9.41 12.50 -1,250,000 12,032,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -100,000 962,560 -9.41 12.50 -1,250,000 12,032,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -100,000 1,162,560 -7.92 10.00 -1,000,000 11,625,600
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -150,000 1,362,560 -9.92 12.50 -1,875,000 17,032,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -400,000 1,512,560 -20.91 12.50 -5,000,000 18,907,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -400,000 1,512,560 -20.91 12.50 -5,000,000 18,907,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -200,000 2,012,560 -9.04 12.50 -2,500,000 25,157,000
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -150,000 2,612,560 -5.43 15.00 -2,250,000 39,188,400
2013-03-20 2013-03-15 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		X - Other -100,000 2,762,560 -3.49 10.00 -1,000,000 27,625,600
2013-03-06 2013-03-05 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 500 64,500 0.78 2.76 1,380 178,020
2013-03-06 2013-03-04 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,000 64,000 1.59 1.94 1,945 124,480
2013-03-06 2013-03-04 4 AEGR Aegerion Pharmaceuticals, Inc.
Call option (right to buy) 		P - Purchase 1,000 2,000 100.00 8.26 8,260 16,520
2013-03-06 2013-03-04 4 AEGR Aegerion Pharmaceuticals, Inc.
Call option (right to buy) 		P - Purchase 1,000 2,000 100.00 8.26 8,260 16,520
2013-02-27 2013-02-25 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 500 63,000 0.80 0.90 450 56,700
2013-02-27 2013-02-25 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -500 62,500 -0.79 1.05 -525 65,625
2013-02-21 2013-02-20 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 500 62,000 0.81 0.78 390 48,360
2013-02-21 2013-02-20 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -500 61,500 -0.81 1.04 -520 63,960
2013-02-21 2013-02-19 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,000 61,000 1.67 0.79 790 48,190
2013-02-21 2013-02-19 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 60,000 -1.64 0.89 -890 53,400
2013-02-13 2013-02-11 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,000 59,000 1.72 2.08 2,080 122,720
2013-02-13 2013-02-11 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 58,000 -1.69 0.38 -380 22,040
2013-02-08 2013-02-07 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,500 57,000 2.70 2.33 3,495 132,810
2013-02-08 2013-02-07 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,500 55,500 -2.63 0.27 -405 14,985
2013-02-08 2013-02-06 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 4,000 54,000 8.00 1.65 6,600 89,100
2013-02-08 2013-02-06 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 50,000 -3.85 0.55 -1,100 27,500
2013-02-06 2013-02-05 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -6,000 48,000 -11.11 0.69 -4,140 33,120
2013-02-06 2013-02-04 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -500 42,000 -1.18 2.05 -1,025 86,100
2013-02-05 2013-02-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 50,000 3,373,426 1.50 27.79 1,389,400 93,740,762
2013-02-04 2013-02-01 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 41,500 -2.35 0.80 -800 33,200
2013-02-01 2013-01-31 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,000 40,500 2.53 1.45 1,450 58,725
2013-02-01 2013-01-31 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 39,500 -2.47 0.88 -875 34,562
2013-02-01 2013-01-30 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 2,000 38,500 5.48 1.32 2,650 51,012
2013-02-01 2013-01-30 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 36,500 -5.19 1.05 -2,100 38,325
2013-01-30 2013-01-29 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 4,000 34,500 13.11 1.71 6,840 58,995
2013-01-30 2013-01-29 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to buy) 		P - Purchase 500 30,500 1.67 0.05 25 1,525
2013-01-30 2013-01-29 4 RPRX REPROS THERAPEUTICS INC.
Call option (right to buy) 		P - Purchase 500 30,000 1.69 0.10 50 3,000
2013-01-30 2013-01-29 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -4,000 29,500 -11.94 0.80 -3,200 23,600
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 2,000 25,500 8.51 1.50 3,000 38,250
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 2,000 23,500 9.30 1.85 3,700 43,475
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 2,000 21,500 10.26 0.65 1,300 13,979
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,500 19,500 8.33 2.87 4,300 55,901
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Put option (right to sell) 		P - Purchase 1,000 18,000 5.88 0.80 800 14,400
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 17,000 -5.56 1.19 -1,190 20,230
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 16,000 -5.88 2.43 -2,428 38,846
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 15,000 -6.25 0.80 -800 12,000
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 14,000 -12.50 1.47 -2,935 20,545
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 12,000 -14.29 1.00 -2,001 12,004
2013-01-30 2013-01-28 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 10,000 -16.67 0.88 -1,757 8,787
2013-01-23 2013-01-22 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -500 8,000 -5.88 0.80 -400 6,400
2013-01-23 2013-01-22 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -500 7,500 -6.25 1.40 -702 10,531
2013-01-22 2013-01-18 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 50,000 3,323,426 1.53 27.62 1,381,000 91,793,026
2013-01-18 2013-01-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 25,000 3,273,426 0.77 26.73 668,142 87,484,601
2013-01-18 2013-01-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 25,000 3,273,426 0.77 26.73 668,142 87,484,601
2013-01-15 2013-01-11 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 150,000 3,223,426 4.88 26.64 3,996,000 85,872,069
2013-01-15 2013-01-11 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 200,000 3,073,426 6.96 27.66 5,531,220 84,998,977
2013-01-15 2013-01-11 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 125,000 2,873,426 4.55 26.64 3,330,000 76,548,069
2013-01-11 2013-01-10 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 7,000 -22.22 1.89 -3,780 13,230
2013-01-04 2013-01-04 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 5,000 -16.67 1.20 -1,200 6,000
2013-01-04 2013-01-04 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 4,000 -20.00 1.91 -1,910 7,640
2013-01-04 2013-01-03 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -2,000 3,000 -40.00 1.35 -2,700 4,050
2013-01-04 2013-01-03 4 RPRX REPROS THERAPEUTICS INC.
Call option (obligation to sell) 		S - Sale -1,000 1,000 -50.00 2.01 -2,010 2,010
2012-12-13 3 ACRX ACELRX PHARMACEUTICALS INC
Common Stock 		5,008,400
2012-12-05 2012-12-04 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		P - Purchase 20,000 2,615,293 0.77 21.27 425,400 55,627,282
2012-12-03 2012-11-28 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 70,000 2,565,293 2.81 21.76 1,523,200 55,820,776
2012-12-03 2012-11-21 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 20,000 2,495,293 0.81 20.75 415,000 51,777,330
2012-12-03 2012-11-20 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 20,000 2,475,293 0.81 21.01 420,200 52,005,906
2012-12-03 2012-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 10,000 2,455,293 0.41 19.50 195,000 47,878,214
2012-12-03 2012-11-07 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 30,000 2,445,293 1.24 21.12 633,600 51,644,588
2012-12-03 2012-11-29 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		P - Purchase 30,000 2,595,293 1.17 22.71 681,300 58,939,104
2012-12-03 2012-10-19 4 AEGR Aegerion Pharmaceuticals, Inc.
CALL OPTION (OBLIGATION TO SELL) 		X - Other -2,475 0 -100.00
2012-12-03 2012-10-19 4 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		X - Other -247,500 2,347,233 -9.54 17.50 -4,331,250 41,076,578
2012-12-03 3 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		2,415,293
2012-12-03 3 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		133,133
2012-12-03 3 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		2,594,733
2012-12-03 3 AEGR Aegerion Pharmaceuticals, Inc.
COMMON STOCK 		133,133
2012-05-15 2012-05-14 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		P - Purchase 59,500 2,862,560 2.12 7.38 439,283 21,133,994
2012-05-14 2012-05-11 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		P - Purchase 25,000 2,803,060 0.90 6.35 158,800 17,805,037
2012-05-14 2012-05-11 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		P - Purchase 145,000 2,778,060 5.51 6.35 921,040 17,646,237
2012-05-11 2012-05-10 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		P - Purchase 15,000 2,633,060 0.57 4.82 72,300 12,691,349
2012-05-11 2012-05-10 4 RPRX REPROS THERAPEUTICS INC.
Common Stock 		P - Purchase 310,000 2,618,060 13.43 4.82 1,493,797 12,615,646
2008-12-03 2008-11-19 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -9,600,000 20,580,260 -31.81 0.15 -1,466,880 3,144,664
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -299,570 0 -100.00 0.15 -45,774
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -400,000 299,570 -57.18 0.15 -61,120 45,774
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -1,943,250 699,570 -73.53 0.14 -273,804 98,569
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -400,000 2,642,820 -13.15 0.16 -64,560 426,551
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -29,740 3,042,820 -0.97 0.16 -4,729 483,808
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -2,696,450 30,180,260 -8.20 0.15 -412,018 4,611,544
2008-12-03 2008-11-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		S - Sale -24,681,360 32,876,710 -42.88 0.14 -3,477,604 4,632,328
2008-06-19 2008-06-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 2,040 3,072,560 0.07 3.23 6,589 9,924,369
2008-06-19 2008-06-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 48,960 57,558,070 0.09 3.23 158,141 185,912,566
2008-06-11 2008-06-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 1,340 3,070,520 0.04 3.36 4,502 10,316,947
2008-06-11 2008-06-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 32,260 57,509,110 0.06 3.36 108,394 193,230,610
2008-06-11 2008-06-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 4,000 3,069,180 0.13 3.43 13,720 10,527,287
2008-06-11 2008-06-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 96,000 57,476,850 0.17 3.43 329,280 197,145,596
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 8,000 3,065,180 0.26 3.15 25,200 9,655,317
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 4,000 3,057,180 0.13 3.37 13,480 10,302,697
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 192,000 57,380,850 0.34 3.15 604,800 180,749,678
2008-06-11 2008-06-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinarry Shares 		P - Purchase 96,000 57,188,850 0.17 3.37 323,520 192,726,424
2008-05-06 2008-05-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 2,000 3,036,140 0.07 3.88 7,760 11,780,223
2008-05-06 2008-05-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 48,000 56,683,890 0.08 3.88 186,240 219,933,493
2008-05-06 2008-05-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 4,200 3,034,140 0.14 3.75 15,750 11,378,025
2008-05-06 2008-05-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 100,800 56,635,890 0.18 3.75 378,000 212,384,588
2008-04-16 2008-04-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 10,000 3,015,650 0.33 3.56 35,579 10,729,381
2008-04-16 2008-04-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 90,000 56,191,770 0.16 3.58 322,011 201,048,534
2008-03-20 2008-03-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,650 2,984,350 0.22 3.12 20,749 9,311,769
2008-03-20 2008-03-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 156,350 55,797,070 0.28 3.12 487,843 174,098,018
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 12,000 2,977,700 0.40 3.32 39,856 9,889,835
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 15,780 2,965,700 0.53 3.33 52,566 9,879,340
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 188,000 55,640,720 0.34 3.32 624,404 184,799,523
2008-03-20 2008-03-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 247,220 55,452,720 0.45 3.33 823,539 184,724,101
2008-03-20 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,000 2,949,920 0.20 3.37 20,240 9,950,965
2008-03-20 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 8,820 2,943,920 0.30 3.38 29,814 9,951,333
2008-03-20 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 9,000 2,935,100 0.31 3.37 30,295 9,879,840
2008-03-20 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 17,400 2,926,100 0.60 3.35 58,292 9,802,728
2008-03-19 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 94,000 55,205,500 0.17 3.37 317,090 186,224,713
2008-03-19 2008-03-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 138,180 55,111,500 0.25 3.38 467,090 186,293,403
2008-03-19 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 272,600 54,973,320 0.50 3.35 913,237 184,166,119
2008-03-19 2008-03-12 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 141,000 54,700,720 0.26 3.37 474,620 184,128,094
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 11,900 2,908,700 0.41 3.30 39,327 9,612,672
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 2,896,800 1.05 3.31 99,351 9,593,333
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 107,100 54,559,720 0.20 3.30 353,944 180,308,963
2008-03-19 2008-03-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 54,452,620 0.87 3.31 1,556,499 180,330,742
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 25,200 2,866,800 0.89 3.28 82,568 9,393,070
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 2,841,600 1.07 3.15 94,500 8,951,040
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 2,811,600 1.08 3.25 97,368 9,125,329
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 394,800 5,398,260 7.89 3.28 1,293,562 17,687,399
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 53,587,820 0.88 3.15 1,480,500 168,801,633
2008-03-19 2008-03-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 53,117,820 0.89 3.25 1,525,432 172,399,197
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 60,000 2,781,600 2.20 3.74 224,268 10,397,064
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 9,020 2,721,600 0.33 3.65 32,893 9,924,859
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 141,440 52,647,820 0.27 3.65 515,789 191,990,805
2008-03-19 2008-03-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 940,000 52,506,380 1.82 3.74 3,513,532 196,258,347
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 39,300 2,712,580 1.47 3.86 151,824 10,479,239
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 15,600 2,673,280 0.59 3.73 58,146 9,964,117
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 244,400 51,566,380 0.48 3.73 910,952 192,203,368
2008-03-19 2008-03-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 615,700 51,321,980 1.21 3.86 2,378,572 198,267,073
2008-03-10 2008-03-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 34,200 2,657,680 1.30 3.94 134,700 10,467,538
2008-03-10 2008-03-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 535,800 50,706,280 1.07 3.94 2,110,302 199,711,754
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,640 2,623,480 0.25 3.99 26,490 10,466,111
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 18,000 2,616,840 0.69 3.98 71,656 10,417,378
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 282,000 50,170,480 0.57 3.98 1,122,614 199,723,664
2008-03-10 2008-03-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 104,060 49,888,480 0.21 3.99 415,137 199,025,102
2008-02-29 2008-02-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,600 2,598,840 0.25 4.01 26,484 10,428,365
2008-02-29 2008-02-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 103,400 49,784,420 0.21 4.01 414,913 199,769,942
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 3,790 2,592,240 0.15 3.95 14,970 10,239,348
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 24,000 2,588,450 0.94 3.91 93,742 10,110,227
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 59,390 49,681,020 0.12 3.95 234,590 196,240,029
2008-02-28 2008-02-26 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 376,000 49,621,630 0.76 3.91 1,468,618 193,817,125
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 46,500 2,564,450 1.85 3.87 179,871 9,919,805
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,000 2,517,950 0.24 3.86 23,159 9,718,783
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 94,000 49,245,630 0.19 3.86 362,821 190,078,283
2008-02-28 2008-02-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 728,500 49,151,630 1.50 3.87 2,817,984 190,128,335
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 12,000 2,511,950 0.48 3.95 47,431 9,928,734
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 2,499,950 1.21 3.95 118,374 9,864,303
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 28,380 2,469,950 1.16 3.95 112,101 9,756,302
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 188,000 48,432,130 0.39 3.95 743,089 191,432,837
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 48,235,130 0.98 3.95 1,854,526 190,326,176
2008-02-28 2008-02-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 444,620 47,765,130 0.94 3.95 1,756,249 188,672,264
2008-02-22 2008-02-20 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 100 2,441,570 0.00 3.84 384 9,375,629
2008-02-22 2008-02-20 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 900 47,320,510 0.00 3.84 3,456 181,710,758
2008-02-19 2008-02-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 360 2,441,470 0.01 3.81 1,371 9,297,606
2008-02-19 2008-02-13 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 5,640 473,196,910 0.00 3.81 21,478 1,802,028,473
2008-02-08 2008-02-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 600 3,441,110 0.02 3.40 2,038 11,686,010
2008-02-08 2008-02-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 9,400 47,313,970 0.02 3.40 31,922 160,678,242
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 21,000 2,440,510 0.87 3.71 77,914 9,054,780
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 120 2,419,510 0.00 3.68 442 8,903,797
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 329,000 47,304,570 0.70 3.71 1,220,656 175,509,416
2008-02-08 2008-02-06 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 1,880 46,975,570 0.00 3.68 6,918 172,870,098
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 9,060 2,419,390 0.38 3.79 34,314 9,163,198
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 6,060 2,410,330 0.25 3.75 22,725 9,038,738
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 141,940 46,973,690 0.30 3.79 537,584 177,908,154
2008-02-06 2008-02-05 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 94,940 46,831,750 0.20 3.75 356,025 175,619,062
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 8,400 2,404,270 0.35 3.87 32,495 9,300,678
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 33,000 2,320,270 1.44 3.88 128,056 9,003,808
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 131,600 46,736,810 0.28 3.87 509,081 180,796,676
2008-02-06 2008-02-04 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary shares 		P - Purchase 517,000 46,605,210 1.12 3.88 2,006,218 180,851,517
2008-02-05 2008-02-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 42,000 2,322,870 1.84 3.69 155,022 8,573,713
2008-02-05 2008-02-01 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 658,000 46,088,210 1.45 3.69 2,428,678 170,111,583
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 2,320,870 1.31 3.43 102,987 7,967,315
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 23,640 2,290,870 1.04 3.50 82,723 8,016,441
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 45,430,210 1.05 3.43 1,613,463 155,957,368
2008-02-05 2008-01-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 370,360 44,960,210 0.83 3.50 1,296,001 157,329,263
2008-02-01 2008-01-30 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 15,000 2,267,230 0.67 3.23 48,456 7,324,060
2008-02-01 2008-01-30 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 235,000 44,589,850 0.53 3.23 759,144 144,043,051
2008-01-30 2008-01-29 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,000 2,252,230 0.27 3.23 19,379 7,274,252
2008-01-30 2008-01-29 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 94,000 44,354,850 0.21 3.23 303,601 143,257,295
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 600 2,246,230 0.03 3.23 1,938 7,255,323
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 40,200 2,245,630 1.82 3.21 129,203 7,217,455
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 9,400 44,260,850 0.02 3.23 30,362 142,962,546
2008-01-30 2008-01-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 629,800 44,251,450 1.44 3.21 2,024,177 142,224,160
2008-01-29 2008-01-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 12,000 2,205,430 0.55 3.24 38,856 7,141,182
2008-01-29 2008-01-25 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 188,000 43,621,650 0.43 3.24 608,744 141,246,903
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 42,300 2,193,430 1.97 2.99 126,477 6,558,356
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 13,800 2,151,130 0.65 2.98 41,124 6,410,367
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 66,270 43,433,650 0.15 2.99 198,147 129,866,614
2008-01-28 2008-01-24 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 216,200 42,770,950 0.51 2.98 644,276 127,457,431
2008-01-28 2008-01-23 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 18,000 2,137,330 0.85 2.88 51,908 6,163,632
2008-01-28 2008-01-23 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 282,000 42,554,750 0.67 2.88 813,232 122,719,388
2008-01-25 2008-01-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 790 2,119,330 0.04 2.90 2,293 6,151,355
2008-01-25 2008-01-22 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 12,520 42,272,750 0.03 2.90 36,339 122,696,657
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 7,560 2,118,540 0.36 3.16 23,888 6,694,163
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 11,820 2,110,980 0.56 3.13 36,994 6,606,945
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 118,440 42,260,230 0.28 3.16 374,247 133,533,875
2008-01-25 2008-01-18 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 185,180 42,141,790 0.44 3.13 579,576 131,895,374
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 11,460 2,099,160 0.55 3.01 34,444 6,309,235
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 9,240 2,087,700 0.44 3.06 28,240 6,380,638
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 144,760 41,956,610 0.35 3.06 442,430 128,231,987
2008-01-25 2008-01-17 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 179,540 41,811,850 0.43 3.01 539,625 125,669,696
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 27,600 2,078,460 1.35 3.06 84,346 6,351,774
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 180 2,008,860 0.01 3.16 568 6,341,368
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 432,400 41,632,310 1.05 3.10 1,340,440 129,060,161
2008-01-25 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 2,820 41,199,910 0.01 3.16 8,902 130,055,756
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 42,000 2,050,680 2.09 3.11 130,712 6,382,126
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 15,000 2,008,680 0.75 3.06 45,909 6,147,766
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 658,000 41,197,090 1.62 3.11 2,047,828 128,213,583
2008-01-25 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 235,000 40,539,090 0.58 3.06 719,241 124,073,939
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 27,600 2,078,460 1.35 3.10 85,560 6,443,226
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 180 2,050,860 0.01 3.16 568 6,473,950
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 432,400 41,632,310 1.05 3.10 1,340,440 129,060,161
2008-01-18 2008-01-16 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 2,820 41,199,910 0.01 3.16 8,902 130,055,756
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 42,000 2,050,680 2.09 3.11 130,712 6,382,126
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 15,000 2,008,680 0.75 3.06 45,909 6,147,766
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 658,000 41,197,090 1.62 3.11 2,047,828 128,213,583
2008-01-18 2008-01-15 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 235,000 40,539,000 0.58 3.06 719,241 124,073,663
2008-01-15 2008-01-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 22,200 1,993,680 1.13 3.41 75,724 6,800,442
2008-01-15 2008-01-14 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 347,800 40,304,090 0.87 3.41 1,186,346 137,477,251
2008-01-15 2008-01-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 28,320 1,971,480 1.46 3.39 96,076 6,688,246
2008-01-15 2008-01-11 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 443,680 39,956,290 1.12 3.39 1,505,184 135,551,714
2008-01-11 2008-01-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 69,000 1,943,160 3.68 3.30 227,748 6,413,788
2008-01-11 2008-01-10 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 1,081,000 39,521,610 2.81 3.30 3,568,057 130,448,978
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 36,000 1,874,160 1.96 3.27 117,896 6,137,687
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 24,060 1,838,160 1.33 3.30 79,283 6,057,105
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 564,000 37,431,610 1.53 3.27 1,847,044 122,584,780
2008-01-11 2008-01-09 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 376,940 37,867,610 1.01 3.30 1,242,093 124,781,348
2008-01-11 2008-01-08 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 30,000 1,814,100 1.68 3.26 97,743 5,910,519
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 20,000 1,784,100 1.13 2.87 57,372 5,117,869
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 81,600 1,764,100 4.85 3.11 253,401 5,478,236
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 6,000 1,682,500 0.36 3.10 18,600 5,215,750
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 1,278,400 37,020,670 3.58 3.11 3,969,943 114,963,989
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 94,000 35,742,270 0.26 3.10 291,400 110,801,037
2008-01-11 2008-01-07 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 180,000 35,648,270 0.51 2.87 516,348 102,260,627
2008-01-11 2007-01-08 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 470,000 37,490,670 1.27 3.26 1,531,307 122,148,352
2008-01-04 2008-01-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 1,222,000 35,045,270 3.61 2.89 3,531,580 101,280,830
2008-01-04 2007-01-02 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 78,000 1,649,500 4.96 2.89 225,420 4,767,055
2008-01-02 2007-12-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 69,000 1,571,500 4.59 2.74 188,750 4,298,838
2008-01-02 2007-12-31 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 1,081,000 33,823,270 3.30 2.74 2,957,076 92,523,555
2008-01-02 2007-12-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 48,000 1,502,500 3.30 2.69 129,226 4,045,030
2008-01-02 2007-12-28 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 752,000 32,742,270 2.35 2.69 2,024,534 88,148,739
2007-12-31 2007-12-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 18,000 1,454,500 1.25 2.60 46,717 3,775,009
2007-12-31 2007-12-27 4 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		P - Purchase 282,000 31,990,270 0.89 2.60 731,903 83,027,547
2007-12-31 3/A XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		31,708,270
2007-12-07 3 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		27,876,060
2007-12-07 3 XTLB XTL BIOPHARMACEUTICALS LTD
Ordinary Shares 		1,436,500
2004-12-06 2004-12-03 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -1,315,000 209,100 -86.28 4.72 -6,200,225 985,906
2004-12-06 2004-12-03 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -50,000 1,524,100 -3.18 4.55 -227,500 6,934,655
2004-12-06 2004-12-03 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -30,000 1,574,100 -1.87 4.35 -130,500 6,847,335
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -273,550 1,604,100 -14.57 4.47 -1,222,221 7,167,119
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,000 1,877,650 0.11 3.98 7,960 7,473,047
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -2,000 1,875,650 -0.11 4.47 -8,936 8,380,404
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -25,000 1,877,650 -1.31 4.90 -122,500 9,200,485
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -70,900 1,902,650 -3.59 4.47 -316,781 8,501,040
2004-12-06 2004-12-02 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -28,550 0 -100.00 4.47 -127,561
2004-10-12 2004-10-08 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 14,900 1,973,550 0.76 9.87 146,991 19,469,465
2004-10-12 2004-10-08 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,000 27,950 3.71 9.87 9,865 275,732
2004-10-08 2004-10-07 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 9,000 1,958,650 0.46 10.11 90,964 19,796,271
2004-10-08 2004-10-07 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,000 26,950 3.85 10.11 10,107 272,386
2004-10-08 2004-10-06 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 9,000 1,949,650 0.46 9.90 89,112 19,304,070
2004-10-08 2004-10-06 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,000 25,950 4.01 9.90 9,901 256,939
2004-10-06 2004-10-05 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 15,800 1,940,650 0.82 9.90 156,417 19,212,047
2004-10-06 2004-10-05 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,700 24,950 7.31 9.90 16,830 247,000
2004-10-06 2004-10-04 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 13,100 1,924,850 0.69 9.72 127,341 18,710,889
2004-10-06 2004-10-04 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,400 23,250 6.41 9.72 13,609 226,006
2004-10-04 2004-10-01 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 19,400 1,911,750 1.03 9.59 186,046 18,333,682
2004-10-04 2004-10-01 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,100 21,850 10.63 9.59 20,139 209,542
2004-10-04 2004-09-30 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 9,000 1,892,350 0.48 8.96 80,680 16,963,972
2004-10-04 2004-09-30 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,000 19,750 5.33 8.96 8,964 177,049
2004-09-16 2004-09-14 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 22,100 1,883,350 1.19 7.69 169,843 14,473,921
2004-09-16 2004-09-14 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,400 18,750 14.68 7.69 18,444 144,098
2004-09-15 2004-09-13 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 23,400 1,861,250 1.27 7.17 167,734 13,341,626
2004-09-15 2004-09-13 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,500 16,350 18.05 7.17 17,920 117,198
2004-09-13 2004-09-09 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 4,300 1,837,850 0.23 6.85 29,455 12,589,272
2004-09-13 2004-09-09 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 400 13,850 2.97 6.85 2,740 94,872
2004-09-01 2004-08-31 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 9,000 1,833,550 0.49 6.84 61,563 12,542,032
2004-09-01 2004-08-30 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 9,000 1,824,550 0.50 6.84 61,537 12,475,178
2004-09-01 2004-08-30 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,000 13,450 8.03 6.84 6,837 91,963
2004-08-20 2004-08-19 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 700 12,450 5.96 5.84 4,091 72,765
2004-08-20 2004-08-19 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,200 1,815,550 0.34 5.84 36,237 10,611,164
2004-08-20 2004-08-18 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 4,500 11,750 62.07 5.83 26,214 68,447
2004-08-20 2004-08-18 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 40,500 1,809,350 2.29 5.83 235,925 10,540,007
2004-08-19 2004-08-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -200 7,250 -2.68 5.50 -1,100 39,875
2004-08-19 2004-08-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 200 7,450 2.76 5.10 1,020 37,995
2004-08-16 2004-08-12 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,500 1,768,850 0.14 4.75 11,875 8,402,038
2004-08-13 2004-08-11 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,300 7,250 46.46 4.72 10,850 34,202
2004-08-13 2004-08-11 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 21,300 1,766,350 1.22 4.72 100,483 8,332,756
2004-07-21 2004-07-19 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 2,800 4,950 130.23 5.67 15,889 28,090
2004-07-21 2004-07-19 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 25,652 1,745,050 1.49 5.67 145,567 9,902,635
2004-07-19 2004-07-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 1,400 2,150 186.67 5.89 8,242 12,657
2004-07-19 2004-07-16 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 12,648 1,719,398 0.74 5.89 74,468 10,123,300
2004-07-19 2004-07-15 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 750 750 5.96 4,472 4,472
2004-07-19 2004-07-15 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,750 1,706,750 0.40 5.96 40,252 10,177,862
2004-05-18 2004-05-14 4/A BPA BIOSANTE PHARMACEUTICALS INC
Warrants 		P - Purchase 97,500 97,500
2004-05-18 2004-05-14 4/A BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 650,000 1,700,000 61.90 6.00 3,900,000 10,200,000
2004-05-12 2004-05-11 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		P - Purchase 650,000 1,700,000 61.90 6.00 3,900,000 10,200,000
2004-02-12 3 ANTR.OB ANTARES PHARMA INC
Common Stock, $0.01 par value per share 		2,700,000
2004-02-05 2004-02-03 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -87,400 1,050,000 -7.68 6.44 -562,576 6,758,640
2004-01-23 2004-01-23 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -35,000 1,137,400 -2.99 5.62 -196,700 6,392,188
2004-01-23 2004-01-22 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -100,000 1,172,400 -7.86 5.68 -568,000 6,659,232
2004-01-23 2004-01-21 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -5,000 1,272,400 -0.39 5.65 -28,250 7,189,060
2004-01-23 2004-01-21 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -15,000 1,277,400 -1.16 5.84 -87,600 7,460,016
2004-01-23 2004-01-21 4 BPA BIOSANTE PHARMACEUTICALS INC
Common Stock 		S - Sale -100,000 1,292,400 -7.18 5.66 -566,000 7,314,984
2003-08-13 3 BISP.OB BIOSANTE PHARMACEUTICALS INC
Common Stock, par value $0.0001 		225,000
2003-08-13 3 BISP.OB BIOSANTE PHARMACEUTICALS INC
Common Stock, par value $0.0001 		1,392,400
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）